input	prediction
Interval	O
Events	O
<EOS>	----
-	O
Had	O
a	B-Sign_or_Symptom
fever	I-Sign_or_Symptom
of	O
39.2	O
and	O
tachycardia	B-Finding
to	O
162	O
at	O
midnight	O
,	O
received	O
acetaminophen	B-Pharmacologic_Substance
and	O
ibuprofen	B-Pharmacologic_Substance
,	O
vitals	B-Health_Care_Activity
were	O
within	O
normal	O
limits	O
rest	O
of	O
night	O
.	O
<EOS>	----
Physical	O
Exam	O
<EOS>	----
Vitals	B-Health_Care_Activity
&	I-CUI_less
Measurements	I-CUI_less
<EOS>	----
T	B-Health_Care_Activity
:	O
38.8	O
Â°	O
C	B-Health_Care_Activity
HR	B-Health_Care_Activity
:	O
128	O
(	O
Monitored	O
)	O
RR	B-Health_Care_Activity
:	O
32	O
BP	B-Health_Care_Activity
:	O
88	O
/	O
70	O
SpO2	B-Laboratory_Procedure
:	O
96	O
%	O
<EOS>	----
Weight	B-Health_Care_Activity
:	O
10.825	O
kg	O
(	O
69	O
%	O
ile	O
)	O
*	O
;	O
Length	B-Health_Care_Activity
:	O
75	O
cm	O
(	O
6	O
%	O
ile	O
)	O
*	O
;	O
Stature	O
Type	O
:	O
Standing	O
;	O
Head	B-Health_Care_Activity
Circumference	I-Organ_or_Tissue_Function
:	O
50	O
cm	O
(	O
99	O
%	O
ile	O
)	O
*	O
<EOS>	----
*	O
WHO	O
chart	O
used	O
to	O
calculate	O
percentile	O
value	O
.	O
<EOS>	----
General	O
:	O
uncomfortable	B-Sign_or_Symptom
-	O
appearing	O
and	O
crying	O
baby	O
,	O
but	O
NAD	O
<EOS>	----
HEENT	O
:	O
NCAT	B-Finding
,	O
no	O
icterus	B-Finding
,	O
no	O
injection	B-Pathologic_Function
,	O
no	O
conjunctivitis	B-Disease_or_Syndrome
,	O
external	O
nares	O
patent	O
with	O
no	O
discharge	B-Finding
,	O
MMM	B-Body_Part,_Organ,_or_Organ_Component
,	O
oropharynx	O
clear	O
and	O
non	B-CUI_less
-	I-CUI_less
erythematous	I-CUI_less
,	O
no	O
oral	B-Finding
lesions	I-Finding
<EOS>	----
Neck	O
:	O
supple	O
and	O
full	O
ROM	O
,	O
R	B-Spatial_Concept
submandibular	B-Body_Part,_Organ,_or_Organ_Component
node	I-Body_Part,_Organ,_or_Organ_Component
enlarged	B-Qualitative_Concept
but	O
mobile	O
<EOS>	----
CV	O
:	O
RRR	B-CUI_less
,	O
no	O
m	O
/	O
r	O
/	O
g	O
,	O
cap	B-Health_Care_Activity
refill	I-Health_Care_Activity
<	O
2	O
sec	O
<EOS>	----
Resp	O
:	O
CTAB	B-Diagnostic_Procedure
,	O
no	O
increased	B-Finding
WOB	I-Finding
<EOS>	----
Abd	O
:	O
soft	O
,	O
nontender	B-Qualitative_Concept
,	O
nondistended	B-Finding
,	O
no	O
HSM	B-Finding
<EOS>	----
Ext	O
:	O
no	O
cyanosis	B-Sign_or_Symptom
,	O
no	O
edema	B-Sign_or_Symptom
,	O
normal	O
muscle	O
strength	O
and	O
tone	O
,	O
moves	O
limbs	O
with	O
intention	O
and	O
freely	O
against	O
gravity	O
<EOS>	----
Neuro	O
:	O
CN3	O
-	O
12	O
grossly	O
intact	O
<EOS>	----
Skin	O
:	O
no	O
rashes	B-Sign_or_Symptom
or	O
erythema	B-Disease_or_Syndrome
<EOS>	----
Assessment	O
/	O
Plan	O
<EOS>	----
W	O
is	O
a	O
14	O
month	O
old	O
boy	O
with	O
a	B-Therapeutic_or_Preventive_Procedure
PMHx	I-Therapeutic_or_Preventive_Procedure
notable	O
for	O
multiple	B-Temporal_Concept
AOM	B-Disease_or_Syndrome
episodes	B-Temporal_Concept
s	O
/	O
p	O
tympanostomy	B-Medical_Device
tubes	I-Medical_Device
who	O
presented	O
with	O
3	O
days	O
of	O
fever	B-Sign_or_Symptom
,	O
conjunctivitis	B-Disease_or_Syndrome
,	O
and	O
facial	B-Sign_or_Symptom
rash	I-Sign_or_Symptom
who	O
had	O
elevated	B-Qualitative_Concept
inflammatory	I-Laboratory_Procedure
markers	I-Laboratory_Procedure
in	O
the	O
ED	O
.	O
Presentation	O
consistent	O
with	O
viral	B-Disease_or_Syndrome
infection	I-Disease_or_Syndrome
,	O
but	O
concern	O
for	O
Kawasaki	B-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
,	O
MIS	B-CUI_less
-	I-CUI_less
C	I-CUI_less
,	O
or	O
more	B-CUI_less
serious	B-Qualitative_Concept
infection	B-Pathologic_Function
.	O
<EOS>	----
Lowered	O
concern	O
for	O
serious	B-Qualitative_Concept
infection	B-Disease_or_Syndrome
due	O
to	O
lack	O
of	O
identifiable	O
source	O
(	O
neg	O
UA	B-Finding
,	O
no	O
neck	B-Sign_or_Symptom
stiffness	I-Sign_or_Symptom
or	O
neuro	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
,	O
blood	B-Laboratory_Procedure
Cx	I-Laboratory_Procedure
no	O
growth	B-Finding
to	O
date	O
,	O
no	O
GI	B-Finding
Sx	I-Finding
such	O
as	O
vomiting	B-Sign_or_Symptom
or	O
diarrhea	B-Sign_or_Symptom
,	O
no	O
breaks	B-Finding
in	I-Finding
skin	I-Finding
)	O
.	O
<EOS>	----
MIS	O
-	O
C	O
less	O
likely	O
i	O
/	O
s	O
/	O
o	O
negative	B-CUI_less
SARS	B-CUI_less
-	I-CUI_less
CoV	I-CUI_less
-	I-CUI_less
2	I-CUI_less
testing	I-CUI_less
.	O
<EOS>	----
Overall	O
collection	O
of	O
symptoms	O
includes	O
several	O
days	O
of	O
fevers	B-Sign_or_Symptom
and	O
multiple	O
(	O
conjunctival	B-Pathologic_Function
injection	I-Pathologic_Function
,	O
exanthem	B-Disease_or_Syndrome
,	O
cracked	B-Finding
lips	I-Finding
,	O
cervical	B-Disease_or_Syndrome
lymphadenopathy	I-Disease_or_Syndrome
)	O
are	O
consistent	O
with	O
Kawasaki	B-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
.	O
<EOS>	----
Improving	O
with	O
better	O
PO	O
,	O
resolution	O
of	O
rash	B-Sign_or_Symptom
and	O
conjunctivitis	B-Disease_or_Syndrome
,	O
and	O
disposition	O
per	O
parents	O
,	O
but	O
continuing	O
to	O
experience	O
intermittent	B-Temporal_Concept
fevers	B-Sign_or_Symptom
.	O
<EOS>	----
Currently	O
requires	O
an	O
inpatient	O
level	O
of	O
care	O
for	O
rehydration	B-Therapeutic_or_Preventive_Procedure
and	O
evaluation	B-Health_Care_Activity
of	O
possible	O
Kawasaki	B-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
incl	O
.	O
<EOS>	----
inflammatory	B-Laboratory_Procedure
markers	I-Laboratory_Procedure
and	O
echocardiogram	B-Diagnostic_Procedure
.	O
<EOS>	----
#	O
CV	O
:	O
HDS	O
<EOS>	----
[	O
]	O
AM	O
Echo	B-Diagnostic_Procedure
<EOS>	----
#	O
Resp	O
:	O
SORA	O
<EOS>	----
#	O
FEN	O
/	O
GI	O
<EOS>	----
-	O
POAL	O
<EOS>	----
#	O
Rheum	O
<EOS>	----
-	O
Rheum	O
consulted	O
,	O
appreciate	O
recs	O
<EOS>	----
-	O
MIS	B-CUI_less
-	O
C	I-CUI_less
labs	B-Laboratory_Procedure
repeated	O
6	O
/	O
8	O
<EOS>	----
#	O
ID	O
<EOS>	----
-	O
COVID	B-Diagnostic_Procedure
PCR	I-Diagnostic_Procedure
and	O
Ab	B-Laboratory_Procedure
NEG	O
<EOS>	----
-	O
RVP	B-Organ_or_Tissue_Function
NEG	O
<EOS>	----
[	O
]	O
Follow	O
-	O
up	O
blood	B-Laboratory_Procedure
cultures	I-Laboratory_Procedure
<EOS>	----
#	O
Dispo	O
<EOS>	----
-	O
Pending	O
KD	B-Disease_or_Syndrome
work	B-CUI_less
-	I-CUI_less
up	I-CUI_less
and	O
rehydration	B-Therapeutic_or_Preventive_Procedure
<EOS>	----
End of note1.txt	----------


Chief	O
Complaint	O
<EOS>	----
Fever	B-Sign_or_Symptom
(	O
Complaint	O
of	O
)	O
<EOS>	----
Arrival	O
Date	O
/	O
Time	O
:	O
11	O
/	O
30	O
/	O
2020	O
15	O
:	O
50	O
:	O
00	O
<EOS>	----
History	O
of	O
Present	O
Illness	O
<EOS>	----
20	O
-	O
year	O
-	O
old	O
previously	O
well	O
here	O
for	O
feeling	O
sick	B-Sign_or_Symptom
since	O
yesterday	O
.	O
<EOS>	----
Since	O
yesterday	O
patient	O
with	O
several	O
episodes	O
of	O
vomiting	B-Sign_or_Symptom
(	O
not	O
bloody	B-CUI_less
or	O
bilious	B-CUI_less
)	O
,	O
few	O
episodes	O
of	O
nonbloody	B-Pathologic_Function
diarrhea	I-Pathologic_Function
,	O
mild	B-Qualitative_Concept
cough	B-Sign_or_Symptom
,	O
diffuse	B-Spatial_Concept
myalgias	B-Sign_or_Symptom
,	O
sore	B-Sign_or_Symptom
throat	I-Sign_or_Symptom
,	O
headache	B-Sign_or_Symptom
(	O
frontal	O
and	O
pounding	O
-	O
no	O
prior	O
h	O
/	O
o	O
migraines	B-Disease_or_Syndrome
,	O
neg	O
FH	O
migraine	B-Disease_or_Syndrome
)	O
,	O
""""	O
everything	O
hurts	O
""""	O
.	O
no	O
significant	B-Idea_or_Concept
nasal	B-Finding
congestion	I-Pathologic_Function
,	O
minimal	B-Qualitative_Concept
cough	B-Sign_or_Symptom
.	O
<EOS>	----
Some	B-Quantitative_Concept
diffuse	B-Spatial_Concept
chest	B-Sign_or_Symptom
discomfort	I-Sign_or_Symptom
-	O
not	O
clearly	B-CUI_less
pleuritic	B-Disease_or_Syndrome
,	O
no	O
palpitations	B-Finding
.	O
<EOS>	----
Also	O
with	O
diffuse	B-Spatial_Concept
abdominal	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
-	O
somewhat	B-CUI_less
colicky	B-Sign_or_Symptom
and	O
moving	O
around	O
.	O
<EOS>	----
Decreased	B-Finding
p.o	I-Finding
.	I-Finding
's	I-Finding
,	O
decreased	B-Disease_or_Syndrome
urine	I-Disease_or_Syndrome
output	I-Disease_or_Syndrome
.	O
<EOS>	----
Patient	O
feels	O
lightheaded	B-Sign_or_Symptom
when	O
standing	O
.	O
<EOS>	----
Unclear	O
if	O
ill	O
contacts	O
-	O
he	O
was	O
with	O
someone	O
yesterday	O
who	O
was	O
sick	O
last	O
week	O
.	O
<EOS>	----
Patient	O
sexually	O
active	O
but	O
denies	O
discharge	O
.	O
<EOS>	----
Family	O
History	O
:	O
Reviewed	O
and	O
no	O
pertinent	O
related	O
family	O
hx	O
pertaining	O
to	O
this	O
visit	O
<EOS>	----
Social	O
History	O
:	O
Lives	O
with	O
family	O
<EOS>	----
Immunizations	O
:	O
Up	O
to	O
date	O
<EOS>	----
Review	O
of	O
Systems	O
<EOS>	----
Pertinent	O
positives	O
and	O
negatives	O
noted	O
above	O
in	O
HPI	O
.	O
All	O
other	O
systems	O
of	O
a	O
10	O
system	O
review	B-CUI_less
are	O
negative	O
.	O
<EOS>	----
Physical	O
Exam	O
<EOS>	----
Temperature	B-Health_Care_Activity
:	O
36.7	O
DegC	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
Systolic	B-Health_Care_Activity
Blood	I-Health_Care_Activity
Pressure	I-Health_Care_Activity
:	O
112	O
mmHg	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
Diastolic	B-Health_Care_Activity
Blood	I-Health_Care_Activity
Pressure	I-Health_Care_Activity
:	O
68	O
mmHg	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
Heart	B-Health_Care_Activity
Rate	I-Health_Care_Activity
:	O
104	O
bpm	O
High	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
Respiratory	B-Health_Care_Activity
Rate	I-Health_Care_Activity
:	O
18	O
br	O
/	O
min	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
Oxygen	B-Laboratory_Procedure
Saturation	I-Laboratory_Procedure
(	O
SPO2	B-Laboratory_Procedure
)	O
:	O
99	O
%	O
(	O
11	O
/	O
30	O
/	O
20	O
16	O
:	O
12	O
:	O
00	O
)	O
<EOS>	----
My	B-Health_Care_Activity
examination	I-Health_Care_Activity
revealed	O
the	O
patient	O
to	O
be	O
tired	B-Sign_or_Symptom
appearing	O
,	O
somewhat	B-CUI_less
uncomfortable	B-Sign_or_Symptom
but	O
nontoxic	B-Qualitative_Concept
,	O
in	O
no	B-CUI_less
acute	I-CUI_less
distress	I-CUI_less
.	O
<EOS>	----
HEENT	O
:	O
eomi	O
perrl	O
.	O
op	O
clear	O
with	O
no	O
signif	B-CUI_less
tonsillar	B-Finding
enlargement	I-Finding
or	O
discharge	B-Finding
<EOS>	----
NECK	O
:	O
supple	O
,	O
FROM	O
.	O
tender	B-CUI_less
musculature	O
posteriorly	O
;	O
no	O
meningismus	B-Sign_or_Symptom
.	O
<EOS>	----
LUNGS	O
:	O
clear	O
and	O
equal	O
BS	O
.	O
<EOS>	----
CHEST	O
wall	O
:	O
diffusely	B-Spatial_Concept
tender	B-Finding
to	O
palpation	B-Diagnostic_Procedure
that	O
pt	O
reports	O
reproduces	O
his	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
<EOS>	----
COR	O
:	O
slt	B-Finding
tachy	B-Finding
,	O
RR	B-Health_Care_Activity
,	O
no	O
abnormal	B-Finding
cardiac	I-Finding
sounds	I-Finding
<EOS>	----
ABD	O
:	O
soft	O
,	O
diffuse	B-Spatial_Concept
tenderness	B-Sign_or_Symptom
.	O
no	O
guarding	B-Sign_or_Symptom
/	O
rebound	B-Sign_or_Symptom
.	O
<EOS>	----
GU	O
:	O
pt	O
reports	O
tenderness	B-Sign_or_Symptom
of	O
entire	B-Body_Part,_Organ,_or_Organ_Component
scrotum	B-Body_Location_or_Region
/	O
testes	B-Body_Part,_Organ,_or_Organ_Component
but	O
no	O
different	O
from	O
entire	B-Sign_or_Symptom
body	B-Sign_or_Symptom
aches	I-Sign_or_Symptom
.	O
<EOS>	----
EXT	O
:	O
MAE	O
spontaneously	O
and	O
equally	O
<EOS>	----
NEURO	O
:	O
nonfocal	O
<EOS>	----
Medical	O
Decision	O
Making	O
<EOS>	----
20	O
-	O
year	O
-	O
old	O
previously	O
well	O
here	O
with	O
1	O
to	O
2	O
days	O
of	O
vomiting	B-Sign_or_Symptom
,	O
and	O
diarrhea	B-Sign_or_Symptom
,	O
sore	B-Sign_or_Symptom
throat	I-Sign_or_Symptom
,	O
headache	B-Sign_or_Symptom
,	O
diffuse	B-Spatial_Concept
myalgias	B-Sign_or_Symptom
/	O
aches	B-Sign_or_Symptom
including	O
abdominal	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
,	O
chest	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
.	O
<EOS>	----
Reproducible	B-Qualitative_Concept
chest	B-Sign_or_Symptom
wall	I-Sign_or_Symptom
tenderness	I-Sign_or_Symptom
,	O
abd	O
not	O
peritoneal	O
,	O
no	O
meningismus	B-Disease_or_Syndrome
and	O
pt	O
reports	O
pain	B-Sign_or_Symptom
with	O
touching	O
anywhere	O
on	O
his	O
body	O
.	O
<EOS>	----
Multiple	B-Quantitative_Concept
symptoms	B-Sign_or_Symptom
likely	O
due	O
to	O
viral	B-Disease_or_Syndrome
illness	I-Disease_or_Syndrome
-	O
no	O
bacterial	B-Finding
source	I-Finding
on	O
exam	B-Health_Care_Activity
however	O
patient	B-Finding
dehydrated	I-Finding
and	O
uncomfortable	B-Sign_or_Symptom
.	O
<EOS>	----
Plan	O
for	O
Covid	B-Pharmacologic_Substance
,	O
rapid	B-CUI_less
strep	I-CUI_less
,	O
fluids	B-Body_Substance
,	O
Zofran	B-Pharmacologic_Substance
,	O
Tylenol	B-Pharmacologic_Substance
,	O
Toradol	B-Pharmacologic_Substance
and	O
reassess	O
.	O
<EOS>	----
If	O
not	O
improved	O
consider	O
further	B-Health_Care_Activity
work	I-Health_Care_Activity
-	I-Health_Care_Activity
up	I-Health_Care_Activity
based	O
on	O
symptoms	B-Sign_or_Symptom
and	O
exam	B-Health_Care_Activity
.	O
<EOS>	----
Reexamination	O
/	O
Reevaluation	O
<EOS>	----
While	O
getting	O
fluid	B-Therapeutic_or_Preventive_Procedure
/	I-Therapeutic_or_Preventive_Procedure
treatment	B-Therapeutic_or_Preventive_Procedure
RN	O
noted	O
a	O
10	O
-	O
second	O
desaturation	B-Pathologic_Function
down	O
to	O
85	O
%	O
with	O
a	O
good	O
tracing	B-Health_Care_Activity
-	O
that	O
self	O
resolved	O
.	O
<EOS>	----
Chest	B-Diagnostic_Procedure
x	I-Diagnostic_Procedure
-	I-Diagnostic_Procedure
ray	I-Diagnostic_Procedure
obtained	O
and	O
negative	O
.	O
<EOS>	----
EKG	B-Diagnostic_Procedure
:	O
Normal	O
sinus	O
rhythm	O
,	O
first	B-Disease_or_Syndrome
-	I-Disease_or_Syndrome
degree	I-Disease_or_Syndrome
heart	I-Disease_or_Syndrome
block	I-Disease_or_Syndrome
,	O
otherwise	O
negative	O
.	O
<EOS>	----
Discussed	O
with	O
cardiology	O
who	O
reviewed	O
EKG	B-Diagnostic_Procedure
:	O
1st	B-Disease_or_Syndrome
degree	I-Disease_or_Syndrome
heart	I-Disease_or_Syndrome
block	I-Disease_or_Syndrome
but	O
no	O
other	B-CUI_less
concerns	O
:	O
Recommended	O
Lyme	B-Laboratory_Procedure
titers	I-Laboratory_Procedure
and	O
repeat	O
as	O
outpatient	O
.	O
<EOS>	----
Labs	B-Laboratory_Procedure
benign	O
as	O
noted	O
.	O
<EOS>	----
With	O
treatment	B-Therapeutic_or_Preventive_Procedure
,	O
normalization	O
of	O
HR	B-Health_Care_Activity
,	O
sat	O
normal	O
after	O
earlier	O
desat	O
and	O
patient	O
with	O
improving	O
clinical	O
course	O
-	O
no	O
chest	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
or	O
shortness	B-Sign_or_Symptom
of	I-Sign_or_Symptom
breath	I-Sign_or_Symptom
,	O
no	O
abdominal	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
,	O
does	O
not	O
feel	O
dizzy	B-Sign_or_Symptom
when	O
standing	O
.	O
<EOS>	----
Headache	B-Sign_or_Symptom
improving	O
but	O
still	O
5	O
out	O
of	O
10	O
.	O
<EOS>	----
Pt	O
alert	O
,	O
improved	O
appearance	O
,	O
HR	B-Health_Care_Activity
80	O
's	O
.	O
,	O
lungs	O
clear	O
,	O
cor	B-Finding
rrr	I-Finding
,	O
abd	B-Finding
soft	O
and	O
nontender	B-Qualitative_Concept
,	O
testes	B-Body_Part,_Organ,_or_Organ_Component
nontender	B-Qualitative_Concept
.	O
<EOS>	----
Plan	O
for	O
Tylenol	B-Pharmacologic_Substance
,	O
p.o	B-Therapeutic_or_Preventive_Procedure
.	I-CUI_less
challenge	B-Therapeutic_or_Preventive_Procedure
and	O
reassessment	B-Health_Care_Activity
.	O
<EOS>	----
Signed	O
out	O
to	O
Dr.	O
B.	O
<EOS>	----
Final	O
Diagnosis	O
<EOS>	----
1	O
.	O
Coronavirus	B-Disease_or_Syndrome
infection	I-Disease_or_Syndrome
B34.2	O
<EOS>	----
2	O
.	O
Fever	B-Sign_or_Symptom
R50.9	O
<EOS>	----
3	O
.	O
Dehydration	B-Finding
E86.0	O
<EOS>	----
Assessment	O
/	O
Plan	O
<EOS>	----
Discharge	O
Instructions	O
<EOS>	----
Dehydration	B-Finding
,	O
Age	O
>	O
1	O
yr	O
<EOS>	----
Dehydration	B-Finding
,	O
Age	O
>	O
1	O
yr	O
<EOS>	----
Fever	B-Sign_or_Symptom
,	O
Age	O
>	O
3	O
yrs	O
<EOS>	----
Coronavirus	B-Disease_or_Syndrome
(	O
COVID	B-Disease_or_Syndrome
-	O
19	O
)	O
,	O
Confirmed	O
<EOS>	----
Follow	O
up	O
<EOS>	----
With	O
<EOS>	----
When	O
<EOS>	----
Contact	O
Information	O
<EOS>	----
Additional	O
Instructions	O
:	O
<EOS>	----
Attending	O
Attestation	O
<EOS>	----
Participated	O
in	O
pt	O
.	O
care	O
:	O
history	O
,	O
MDM	O
<EOS>	----
Personally	O
performed	O
:	O
history	O
,	O
exam	B-CUI_less
<EOS>	----
Case	O
discussed	O
with	O
:	O
colleague	O
<EOS>	----
Procedures	O
:	O
no	O
procedure	O
performed	O
,	O
_	O
,	O
_	O
<EOS>	----
E	O
&	O
M	O
service	O
:	O
agree	O
<EOS>	----
Results	O
Interpretation	O
:	O
agree	O
<EOS>	----
I	O
received	O
signout	O
from	O
my	O
colleague	O
Dr.	O
S	O
at	O
10	O
PM	O
at	O
change	O
of	O
shift	O
.	O
<EOS>	----
In	O
brief	O
,	O
patient	O
is	O
a	O
20	O
-	O
year	O
-	O
old	O
otherwise	O
healthy	O
male	O
who	O
presents	O
today	O
with	O
1	O
day	O
of	O
fever	B-Sign_or_Symptom
,	O
vomiting	B-Sign_or_Symptom
,	O
diarrhea	B-Sign_or_Symptom
,	O
cough	B-Sign_or_Symptom
,	O
myalgia	B-Sign_or_Symptom
,	O
sore	B-Sign_or_Symptom
throat	I-Sign_or_Symptom
and	O
headache	B-Sign_or_Symptom
.	O
<EOS>	----
He	O
states	O
that	O
everything	O
hurts	O
.	O
<EOS>	----
Some	B-Quantitative_Concept
mild	B-Qualitative_Concept
chest	B-Sign_or_Symptom
discomfort	I-Sign_or_Symptom
but	O
no	O
signs	O
of	O
increased	B-Finding
work	I-Finding
of	I-Finding
breathing	I-Finding
.	O
<EOS>	----
Has	O
had	O
some	B-Quantitative_Concept
decreased	B-Finding
p.o	I-Finding
.	I-Finding
intake	I-Finding
but	O
normal	O
urine	O
output	O
.	O
<EOS>	----
No	O
known	O
sick	O
contacts	O
.	O
<EOS>	----
No	O
dysuria	B-Sign_or_Symptom
or	O
penile	B-Finding
discharge	I-Finding
.	O
<EOS>	----
Patient	O
had	O
a	O
brief	O
desat	O
on	O
the	B-Medical_Device
monitor	I-Medical_Device
but	O
otherwise	O
has	O
had	O
stable	O
vital	O
signs	O
.	O
<EOS>	----
His	B-Health_Care_Activity
exam	I-Health_Care_Activity
is	O
reassuring	O
and	O
he	O
is	O
walk	O
around	O
the	O
room	O
in	O
no	B-CUI_less
acute	I-CUI_less
distress	I-CUI_less
.	O
<EOS>	----
He	O
had	O
lab	B-Health_Care_Activity
work	I-Health_Care_Activity
that	O
was	O
done	O
that	O
was	O
significant	O
for	O
normal	O
CBC	O
without	O
leukocytosis	B-Finding
.	O
<EOS>	----
He	O
has	O
normal	O
chemistries	O
and	O
a	O
mildly	B-Qualitative_Concept
elevated	B-Qualitative_Concept
CK	B-Laboratory_Procedure
at	O
204	O
.	O
<EOS>	----
He	O
had	O
a	O
negative	O
rapid	B-CUI_less
strep	I-Laboratory_Procedure
but	O
was	O
found	O
to	O
be	O
Covid	B-Laboratory_Procedure
positive	O
.	O
<EOS>	----
Patient	O
received	O
Toradol	B-Pharmacologic_Substance
,	O
dance	B-CUI_less
drawn	I-CUI_less
,	O
Tylenol	B-Pharmacologic_Substance
and	O
fluids	B-Body_Substance
with	O
improvement	O
of	O
his	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
.	O
<EOS>	----
I	O
discussed	O
with	O
this	O
patient	O
over	O
the	O
phone	O
about	O
his	O
Covid	O
positive	O
status	O
and	O
after	O
shared	O
decision	O
making	O
the	O
plan	O
will	O
be	O
for	O
discharge	O
home	O
as	O
the	O
patient	O
is	O
otherwise	O
hemodynamically	O
stable	O
.	O
<EOS>	----
I	O
reviewed	O
strict	B-Qualitative_Concept
return	B-Therapeutic_or_Preventive_Procedure
precautions	I-Therapeutic_or_Preventive_Procedure
with	O
the	O
patient	O
and	O
should	O
prompt	O
a	O
return	O
here	O
to	O
the	O
emergency	O
room	O
versus	O
primary	O
care	O
doctor	O
.	O
<EOS>	----
Urged	O
patient	O
to	O
get	O
a	O
home	B-Spatial_Concept
pulse	B-Health_Care_Activity
ox	I-Health_Care_Activity
if	O
available	O
.	O
<EOS>	----
Patient	O
was	O
able	O
to	O
ambulate	O
here	O
with	O
normal	O
oxygen	O
saturation	O
.	O
<EOS>	----
Urged	O
patient	O
to	O
strictly	O
self	O
quarantine	O
for	O
14	O
days	O
and	O
to	O
answer	O
the	O
phone	O
for	O
contact	O
tracers	O
if	O
they	O
may	O
call	O
.	O
<EOS>	----
Answered	O
the	O
patient	O
's	O
questions	O
over	O
the	O
phone	O
.	O
<EOS>	----
At	O
this	O
time	O
I	O
feel	O
the	O
patient	O
is	O
safe	O
for	O
discharge	O
home	O
with	O
close	O
primary	O
care	O
follow	O
-	O
up	O
and	O
with	O
strict	B-CUI_less
return	B-CUI_less
precautions	I-CUI_less
.	O
<EOS>	----
At	O
this	O
time	O
the	O
patient	O
is	O
stable	O
and	O
safe	O
for	O
discharge	O
home	O
with	O
close	O
primary	O
care	O
follow	O
-	O
up	O
.	O
<EOS>	----
I	O
have	O
counseled	O
parents	O
extensively	O
on	O
signs	B-Sign_or_Symptom
&	I-CUI_less
symptoms	I-Sign_or_Symptom
that	O
should	O
prompt	O
a	O
visit	O
to	O
the	O
primary	O
care	O
doctor	O
or	O
an	O
urgent	O
return	O
here	O
back	O
to	O
the	O
emergency	O
room	O
,	O
including	O
any	B-CUI_less
concerning	B-CUI_less
signs	B-Sign_or_Symptom
or	I-CUI_less
symptoms	I-Sign_or_Symptom
pertaining	O
to	O
the	O
child	O
's	O
diagnosis	O
or	O
any	B-CUI_less
symptoms	I-Sign_or_Symptom
concerning	O
to	O
parents	O
.	O
<EOS>	----
Reviewed	O
home	B-Health_Care_Activity
care	I-Health_Care_Activity
instructions	B-Therapeutic_or_Preventive_Procedure
.	O
<EOS>	----
Caretaker	O
in	O
agreement	O
with	O
plan	O
and	O
all	O
questions	O
were	O
addressed	O
.	O
<EOS>	----
Advised	O
patient	O
to	O
follow	O
up	O
with	O
primary	O
care	O
doctor	O
in	O
24	O
-	O
48	O
hours	O
.	O
<EOS>	----
End of note2.txt	----------


Basic	O
Information	O
<EOS>	----
Time	O
seen	O
:	O
Immediately	O
upon	O
arrival	O
.	O
<EOS>	----
History	O
source	O
:	O
Mother	O
,	O
caretaker	O
.	O
<EOS>	----
History	O
of	O
Present	O
Illness	O
<EOS>	----
Patient	O
is	O
a	O
13	O
yo	O
M	O
w	O
/	O
h	O
/	O
o	O
mitochondiral	B-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
,	O
neuromuscular	B-Disease_or_Syndrome
scoliosis	I-Disease_or_Syndrome
,	O
epilespy	B-Disease_or_Syndrome
,	O
GJ	B-Disease_or_Syndrome
dependence	I-Disease_or_Syndrome
,	O
pancytopenia	B-Disease_or_Syndrome
,	O
nonverbal	B-Finding
,	O
status	O
post	O
spinal	B-Therapeutic_or_Preventive_Procedure
fusion	I-Therapeutic_or_Preventive_Procedure
on	O
8	O
/	O
1	O
presenting	O
with	O
persistent	B-Functional_Concept
tachycardia	B-Finding
since	O
surgery	B-Therapeutic_or_Preventive_Procedure
.	O
<EOS>	----
He	O
was	O
recently	O
admitted	O
6	O
/	O
26	O
-	O
8	O
/	O
02	O
for	O
similar	O
presentation	O
of	O
persistent	B-Functional_Concept
tachycardia	B-Finding
with	O
concern	O
for	O
pain	B-Sign_or_Symptom
.	O
<EOS>	----
During	O
that	O
admission	O
,	O
had	O
extensive	B-Qualitative_Concept
workup	B-CUI_less
including	O
a	O
normal	O
EEG	O
,	O
CXR	B-Diagnostic_Procedure
,	O
CTPE	B-Diagnostic_Procedure
,	O
he	O
remained	O
afebrile	B-Finding
and	O
was	O
ultimately	O
discharged	O
with	O
persistent	B-Functional_Concept
tachycardia	B-Finding
in	O
the	O
120s	O
with	O
unknown	O
etiology	O
.	O
<EOS>	----
Since	O
discharge	O
,	O
mom	O
notes	O
that	O
patient	O
has	O
been	O
persistently	B-Functional_Concept
tachycardic	B-Finding
in	O
the	O
110s	O
-	O
150s	O
,	O
the	O
lowest	O
his	B-Health_Care_Activity
HR	I-Health_Care_Activity
ever	O
gets	O
is	O
in	O
the	O
110s	O
while	O
sleeping	O
.	O
<EOS>	----
RR	B-Health_Care_Activity
has	O
also	O
been	O
elevated	O
at	O
20	O
-	O
24	O
.	O
<EOS>	----
O2	B-Laboratory_Procedure
sat	I-Laboratory_Procedure
95	O
-	O
100	O
%	O
with	O
no	O
hypoxic	B-Finding
episodes	B-Temporal_Concept
.	O
<EOS>	----
Mom	O
thinks	O
that	O
he	O
has	O
been	O
arching	O
his	O
back	O
intermittently	O
and	O
appears	O
to	O
have	O
abdominal	B-Sign_or_Symptom
discomfort	I-Sign_or_Symptom
.	O
<EOS>	----
Mom	O
thinks	O
his	O
urine	O
has	O
been	O
darker	O
than	O
baseline	O
.	O
<EOS>	----
Coming	O
in	O
today	O
due	O
to	O
persistent	B-Pathologic_Function
tachycardia	I-Disease_or_Syndrome
.	O
<EOS>	----
No	O
fevers	B-Sign_or_Symptom
,	O
cough	B-Sign_or_Symptom
,	O
vomiting	B-Sign_or_Symptom
,	O
diarrhea	B-Sign_or_Symptom
,	O
sneezing	B-Finding
,	O
sick	O
contacts	O
.	O
<EOS>	----
Review	O
of	O
Systems	O
<EOS>	----
Constitutional	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
:	O
denies	O
fever	B-Sign_or_Symptom
.	O
<EOS>	----
Skin	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
:	O
denies	O
rash	B-Sign_or_Symptom
.	O
<EOS>	----
Respiratory	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
:	O
denies	O
shortness	B-Sign_or_Symptom
of	I-Sign_or_Symptom
breath	I-Sign_or_Symptom
,	O
denies	O
cough	B-Sign_or_Symptom
,	O
denies	O
wheezing	B-Sign_or_Symptom
.	O
<EOS>	----
Cardiovascular	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
:	O
Tachycardia	B-Finding
.	O
<EOS>	----
Gastrointestinal	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
:	O
no	O
vomiting	B-Sign_or_Symptom
,	O
no	O
nausea	B-Sign_or_Symptom
.	O
<EOS>	----
Neurologic	B-Finding
symptoms	I-Finding
:	O
no	B-Finding
altered	I-Finding
level	I-Finding
of	I-Finding
consciousness	I-Finding
.	O
<EOS>	----
Psychiatric	B-Mental_or_Behavioral_Dysfunction
symptoms	I-Sign_or_Symptom
:	O
no	O
sleeping	B-Finding
problems	I-Finding
.	O
<EOS>	----
Additional	B-CUI_less
review	I-Health_Care_Activity
of	O
systems	B-Health_Care_Activity
information	I-Health_Care_Activity
:	O
10	O
systems	O
reviewed	O
and	O
negative	O
except	O
as	O
noted	O
above	O
..	O
<EOS>	----
Health	O
Status	O
<EOS>	----
Allergies	O
:	O
<EOS>	----
Allergic	B-Pathologic_Function
Reactions	I-Pathologic_Function
(	O
All	O
)	O
<EOS>	----
Severity	O
Not	O
Documented	O
<EOS>	----
Augmentin	B-Pharmacologic_Substance
-	O
Abdominal	B-Body_Location_or_Region
cramping	B-Sign_or_Symptom
.	O
and	O
diarrhea	B-Sign_or_Symptom
.	O
<EOS>	----
Tegaderm	B-Pharmacologic_Substance
-	O
No	O
reactions	O
were	O
documented	O
.	O
<EOS>	----
Nonallergic	B-Pathologic_Function
Reactions	I-Pathologic_Function
(	O
All	I-Pathologic_Function
)	O
<EOS>	----
Severity	O
Not	O
Documented	O
<EOS>	----
Albuterol	B-Pharmacologic_Substance
-	O
Tachycardia	B-Finding
.	O
<EOS>	----
Canceled	O
/	O
Inactive	O
Reactions	O
(	O
All	O
)	O
<EOS>	----
Severity	O
Not	O
Documented	O
<EOS>	----
Amikacin	B-Antibiotic
-	O
Epistaxis	B-Pathologic_Function
.	O
<EOS>	----
Bactrim	B-Pharmacologic_Substance
-	O
Diarrhea	B-Sign_or_Symptom
and	O
abdominal	B-Sign_or_Symptom
cramping	I-Sign_or_Symptom
..	O
<EOS>	----
Latex	B-CUI_less
-	O
No	O
reactions	O
were	O
documented	O
.	O
<EOS>	----
No	B-Finding
known	I-Finding
allergies	I-Finding
.	O
<EOS>	----
Medications	O
:	O
(	O
Selected	O
)	O
<EOS>	----
Inpatient	O
Medications	O
<EOS>	----
Ordered	O
<EOS>	----
cloBAZam	B-Pharmacologic_Substance
:	O
GTUBE	B-Pharmacologic_Substance
20	O
mg	O
,	O
1time	O
,	O
Dose	O
Form	O
=	O
Tablet	O
,	O
Stop	O
09	O
/	O
12	O
/	O
20	O
22	O
:	O
00	O
:	O
00	O
EDT	O
<EOS>	----
cloBAZam	B-Pharmacologic_Substance
:	O
GTUBE	B-Pharmacologic_Substance
40	O
mg	O
,	O
1time	O
,	O
Dose	O
Form	O
=	O
Tablet	O
,	O
Stop	O
09	O
/	O
12	O
/	O
20	O
20	O
:	O
30	O
:	O
00	O
EDT	O
<EOS>	----
lidocaine	B-Clinical_Drug
5	I-Clinical_Drug
%	I-Clinical_Drug
topical	I-Clinical_Drug
film	I-Clinical_Drug
:	O
TD	O
1	O
patch	O
,	O
1time	O
,	O
Dose	O
Form	O
=	O
Patch	O
,	O
Stop	O
09	O
/	O
12	O
/	O
20	O
21	O
:	O
00	O
:	O
00	O
EDT	O
<EOS>	----
melatonin	B-Pharmacologic_Substance
:	O
GTUBE	B-Pharmacologic_Substance
12	O
mg	O
,	O
1time	O
,	O
Dose	O
Form	O
=	O
Tablet	O
,	O
Stop	O
09	O
/	O
12	O
/	O
20	O
20	O
:	O
30	O
:	O
00	O
EDT	O
<EOS>	----
povidone	B-Clinical_Drug
iodine	I-Clinical_Drug
0.35	O
%	O
irrigation	B-Therapeutic_or_Preventive_Procedure
:	O
Site	B-Therapeutic_or_Preventive_Procedure
Irrigation	I-Therapeutic_or_Preventive_Procedure
1	O
appl	O
,	O
1time	O
,	O
Dose	O
Form	O
=	O
Irrigation	B-Therapeutic_or_Preventive_Procedure
,	O
Stop	O
08	O
/	O
10	O
/	O
20	O
10	O
:	O
00	O
:	O
00	O
EDT	O
<EOS>	----
Prescriptions	O
<EOS>	----
Prescribed	O
<EOS>	----
12FR	O
Gentle	B-Qualitative_Concept
Catheter	B-Medical_Device
,	O
Coude	O
Tip	I-Spatial_Concept
:	O
12FR	O
Gentle	B-Qualitative_Concept
Catheter	B-Medical_Device
,	O
Coude	O
Tip	I-Spatial_Concept
Special	O
Instructions	O
:	O
To	O
empty	O
bladder	O
6x	O
/	O
day	O
<EOS>	----
Please	O
include	O
lubricants	B-Clinical_Drug
and	O
wipes	B-Medical_Device
.	O
<EOS>	----
Rx	O
Indication	O
:	O
Urinary	B-Disease_or_Syndrome
Retention	I-Pathologic_Function
Dispense	O
Quantity	O
:	O
180	O
EA	O
<EOS>	----
Refills	O
:	O
12	O
Stop	O
:	O
09	O
/	O
16	O
/	O
20	O
23	O
:	O
59	O
:	O
00	O
EDT	O
See	O
Instructions	O
<EOS>	----
3ml	B-Medical_Device
Syringes	I-Medical_Device
with	I-Medical_Device
Needles	I-Medical_Device
:	O
3ml	B-Medical_Device
Syringes	I-Medical_Device
with	I-Medical_Device
Needles	I-Medical_Device
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
use	O
as	O
directed	O
with	O
amikacin	B-Antibiotic
,	O
Dispense	O
Quantity	O
:	O
90	O
EA	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
06	O
/	O
13	O
/	O
20	O
9	O
:	O
11	O
:	O
00	O
EDT	O
,	O
CarePlus	O
(	O
CVS	O
Specialty	O
)	O
#	O
2971	O
<EOS>	----
3ml	B-Medical_Device
Syringes	I-Medical_Device
with	I-Medical_Device
Needles	I-Medical_Device
:	O
3ml	B-Medical_Device
Syringes	I-Medical_Device
with	I-Medical_Device
Needles	I-Medical_Device
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
use	O
as	O
directed	O
with	O
amikcain	O
,	O
Dispense	O
Quantity	O
:	O
90	O
EA	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
02	O
/	O
19	O
/	O
20	O
12	O
:	O
13	O
:	O
00	O
EST	O
,	O
CarePlus	O
(	O
CVS	O
Specialty	O
)	O
#	O
2971	O
<EOS>	----
Catapres	B-Clinical_Drug
-	I-Clinical_Drug
TTS	I-Clinical_Drug
-	O
3	O
0.3	O
mg	O
/	O
24	O
hr	O
transdermal	B-Clinical_Drug
film	I-Clinical_Drug
,	O
extended	B-Functional_Concept
release	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
1	O
patch	O
,	O
TOP	O
,	O
Weekly	O
,	O
Dispense	O
Quantity	O
:	O
13	O
patch	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
06	O
/	O
09	O
/	O
20	O
9	O
:	O
22	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
Coenzyme	B-Pharmacologic_Substance
Q10	I-Pharmacologic_Substance
150mg	O
/	O
Lipoic	B-Pharmacologic_Substance
Acid	I-Pharmacologic_Substance
150mg	O
/	O
5ml	O
:	O
Coenzyme	B-Pharmacologic_Substance
Q10	I-Pharmacologic_Substance
150mg	O
/	O
Lipoic	B-Pharmacologic_Substance
Acid	I-Pharmacologic_Substance
150mg	O
/	O
5ml	O
,	O
Dose	O
Amount	O
:	O
5	O
mL	O
,	O
GTUBE	O
,	O
BID	O
,	O
Dispense	O
Quantity	O
:	O
300	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
05	O
/	O
13	O
/	O
20	O
15	O
:	O
36	O
:	O
00	O
EDT	O
,	O
ACC	O
Apothecary	O
<EOS>	----
Depakene	B-Pharmacologic_Substance
250	O
mg	O
/	O
5	O
mL	O
oral	B-Clinical_Drug
liquid	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
6	O
ml	O
6	O
am	O
,	O
7ml	O
noon	O
,	O
6ml	O
6	O
pm	O
,	O
7	O
ml	O
nidnight	O
,	O
all	O
doses	O
per	O
G	O
tube	O
90	O
day	O
supply	O
<EOS>	----
(	O
MUST	O
BE	O
PAI	O
MANUFACTURER	O
ONLY	O
)	O
,	O
Dispense	O
Quantity	O
:	O
4	O
,	O
920	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
08	O
/	O
23	O
/	O
20	O
7	O
:	O
44	O
:	O
00	O
EDT	O
<EOS>	----
Florastor	O
Kids	O
250	O
mg	O
oral	O
powder	I-Clinical_Drug
for	O
reconstitution	O
:	O
Dose	O
Amount	O
:	O
1	O
packet	O
,	O
GTUBE	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
30	O
EA	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
03	O
/	O
05	O
/	O
20	O
10	O
:	O
00	O
:	O
00	O
EST	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
Gloves	B-Medical_Device
(	O
size	O
medium	O
or	O
large	O
)	O
:	O
Gloves	B-Medical_Device
(	O
size	O
medium	O
or	O
large	O
)	O
Special	O
Instructions	O
:	O
to	O
be	O
used	O
for	O
daily	B-Health_Care_Activity
personal	I-Health_Care_Activity
hygiene	I-Health_Care_Activity
.	O
<EOS>	----
Diagnosis	O
:	O
incontinence	O
,	O
choreoathetosis	B-Disease_or_Syndrome
Dispense	O
Quantity	O
:	O
4	O
EA	O
<EOS>	----
Refills	O
:	O
11	O
Stop	O
:	O
09	O
/	O
12	O
/	O
20	O
23	O
:	O
59	O
:	O
00	O
EDT	O
See	O
Instructions	O
<EOS>	----
Insert	B-Medical_Device
liners	O
:	O
Insert	B-Medical_Device
liners	I-Medical_Device
Special	O
Instructions	O
:	O
To	O
be	O
used	O
with	O
diapers	O
.	O
<EOS>	----
Diagnosis	O
:	O
incontinence	B-Finding
and	O
choreoathetosis	B-Disease_or_Syndrome
.	O
<EOS>	----
Dispense	O
Quantity	O
:	O
240	O
EA	O
<EOS>	----
Refills	O
:	O
11	O
Stop	O
:	O
09	O
/	O
12	O
/	O
20	O
23	O
:	O
59	O
:	O
00	O
EDT	O
See	O
Instructions	O
<EOS>	----
K	B-Pharmacologic_Substance
-	I-Pharmacologic_Substance
Phos	I-Pharmacologic_Substance
Original	B-CUI_less
500	O
mg	O
oral	O
tablet	O
:	O
Dose	O
:	O
500	O
mg	O
,	O
Dose	O
Amount	O
:	O
1	O
tab	O
,	O
PO	O
,	O
TID	O
,	O
Special	O
Instructions	O
:	O
Take	O
separately	O
from	O
calcium	B-Pharmacologic_Substance
supplement	I-Pharmacologic_Substance
by	O
at	O
least	O
2	O
hours	O
,	O
Dispense	O
Quantity	O
:	O
270	O
tab	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
05	O
/	O
13	O
/	O
20	O
14	O
:	O
04	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
LaMICtal	B-Pharmacologic_Substance
100	O
mg	O
oral	O
tablet	O
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
5	O
tabs	O
(	O
500	O
mgs	O
)	O
q	O
am	O
per	O
G	O
tube	O
<EOS>	----
Brand	O
Name	O
Only	O
<EOS>	----
90	O
day	O
supply	O
,	O
Dispense	O
Quantity	O
:	O
450	O
tab	O
,	O
Refills	O
:	O
2	O
,	O
Entered	O
:	O
04	O
/	O
13	O
/	O
20	O
16	O
:	O
26	O
:	O
00	O
EDT	O
,	O
Dispense	O
as	O
Written	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
Melatonin	B-Pharmacologic_Substance
3mg	O
/	O
ml	O
:	O
Melatonin	B-Pharmacologic_Substance
3mg	O
/	O
ml	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
compunded	O
to	O
3mg	O
/	O
ml	O
concentration	O
.	O
Give	O
4ml	O
via	O
GT	O
QHS	O
<EOS>	----
Please	O
provide	O
90	O
Day	O
supply	O
,	O
Dispense	O
Quantity	O
:	O
360	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
06	O
/	O
09	O
/	O
20	O
9	O
:	O
22	O
:	O
00	O
EDT	O
,	O
ACC	O
Apothecary	O
<EOS>	----
MiraLax	B-Clinical_Drug
oral	I-Clinical_Drug
powder	I-Clinical_Drug
for	O
reconstitution	O
:	O
Dose	O
:	O
17	O
g	O
,	O
GTUBE	O
,	O
TID	O
,	O
Special	O
Instructions	O
:	O
may	O
divide	O
the	B-Clinical_Drug
medication	I-Clinical_Drug
into	O
1	O
or	O
2	O
doses	O
if	O
more	O
convienent	O
,	O
Dispense	O
Quantity	O
:	O
1530	O
g	O
,	O
<EOS>	----
Refills	O
:	O
3	O
,	O
Entered	O
:	O
06	O
/	O
11	O
/	O
20	O
17	O
:	O
20	O
:	O
00	O
EDT	O
,	O
<EOS>	----
Indication	O
:	O
constipation	B-Sign_or_Symptom
for	O
pts	O
5	O
-	O
12	O
yo	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
Onfi	B-Pharmacologic_Substance
2.5	O
mg	O
/	O
mL	O
oral	B-Clinical_Drug
suspension	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
7.5	O
mg	O
(	O
3	O
mLs	O
)	O
pgt	O
qAM	O
and	O
8.75	O
mg	O
(	O
3.5	O
mLs	O
)	O
pgt	O
qAfternoon	O
.	O
<EOS>	----
Also	O
uses	O
tabs	O
for	O
later	O
dosings	O
.	O
,	O
Dispense	O
Quantity	O
:	O
195	O
mL	O
,	O
<EOS>	----
Refills	O
:	O
5	O
,	O
Entered	O
:	O
04	O
/	O
28	O
/	O
20	O
6	O
:	O
26	O
:	O
00	O
EDT	O
,	O
Dispense	O
as	O
Written	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
ResMed	B-CUI_less
AirCurve	I-CUI_less
10ST	O
-	O
A	O
set	O
to	O
BiPAP	B-CUI_less
of	O
20	O
/	O
11	O
cmH2O	O
with	O
a	O
backup	O
rate	O
of	O
18	O
breaths	O
/	O
minute	O
with	O
mas	B-CUI_less
...	O
:	O
ResMed	B-CUI_less
AirCurve	I-CUI_less
10ST	O
-	O
A	O
set	O
to	O
BiPAP	B-CUI_less
of	O
20	O
/	O
11	O
cmH2O	O
with	O
a	O
backup	O
rate	O
of	O
18	O
breaths	O
/	O
minute	O
with	O
mask	B-Medical_Device
,	O
cushions	B-Medical_Device
,	O
headgear	B-Medical_Device
,	O
tubing	B-Medical_Device
,	O
filters	B-Medical_Device
,	O
heated	B-Medical_Device
humidifier	I-Medical_Device
,	O
downloadable	O
compliance	O
information	O
Special	O
Instructions	O
:	O
Replacement	B-Therapeutic_or_Preventive_Procedure
machine	I-Medical_Device
for	O
broken	B-Finding
mach	O
...	O
<EOS>	----
Solu	B-Pharmacologic_Substance
-	I-Pharmacologic_Substance
CORTEF	I-Pharmacologic_Substance
Act	O
-	O
O	O
-	O
Vial	O
100	O
mg	O
injection	O
:	O
Dose	O
:	O
100	O
mg	O
,	O
IM	O
,	O
OUT	O
-	O
PT	O
as	O
directed	O
,	O
PRN	O
EMERGENCY	O
illness	O
,	O
unresponsive	B-Finding
,	O
unable	B-Finding
to	I-Finding
tolerate	I-Finding
oral	B-Finding
meds	I-Finding
,	O
vomiting	B-Sign_or_Symptom
,	O
severe	B-Qualitative_Concept
lethargy	B-Sign_or_Symptom
,	O
etc	O
.	O
,	O
Dispense	O
Quantity	O
:	O
2	O
EA	O
,	O
Refills	O
:	O
11	O
,	O
Entered	O
:	O
10	O
/	O
03	O
/	O
19	O
13	O
:	O
43	O
:	O
07	O
EDT	O
,	O
Dispense	O
as	O
Written	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
Underpads	O
(	O
disposable	O
and	O
reusable	O
)	O
:	O
Underpads	O
(	O
disposable	O
and	O
reusable	O
)	O
Special	O
Instructions	O
:	O
To	O
be	O
used	O
for	O
incontinence	B-Pathologic_Function
.	O
<EOS>	----
Diagnosis	O
:	O
incontinence	B-Finding
,	O
epilepsy	B-Disease_or_Syndrome
and	O
choreoathetosis	B-Disease_or_Syndrome
Dispense	O
Quantity	O
:	O
2	O
EA	O
<EOS>	----
Refills	O
:	O
11	O
Stop	O
:	O
09	O
/	O
12	O
/	O
20	O
23	O
:	O
59	O
:	O
00	O
EDT	O
See	O
Instructions	O
<EOS>	----
acetaminophen	B-Pharmacologic_Substance
160	O
mg	O
/	O
5	O
mL	O
oral	O
liquid	I-Clinical_Drug
:	O
Dose	O
:	O
480	O
mg	O
,	O
Dose	O
Amount	O
:	O
15	O
mL	O
,	O
PO	O
,	O
Q4hr	O
,	O
PRN	O
Fever	B-Sign_or_Symptom
(	O
Temp	B-Health_Care_Activity
>	O
/	O
=	O
37.5	O
degrees	I-CUI_less
Celsius	I-CUI_less
)	O
,	O
Dispense	O
Quantity	O
:	O
480	O
mL	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
07	O
/	O
10	O
/	O
20	O
13	O
:	O
21	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
amikacin	B-Antibiotic
250	O
mg	O
/	O
mL	O
injectable	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
250	O
mg	O
,	O
INH	B-Pharmacologic_Substance
,	O
Q8hr	O
,	O
Special	O
Instructions	O
:	O
Dilute	O
in	O
3ml	O
of	O
sterile	O
water	O
and	O
nebulize	B-Therapeutic_or_Preventive_Procedure
3	O
times	O
/day	O
<EOS>	----
for	O
28	O
days	O
.	O
<EOS>	----
alternate	O
every	O
other	O
month	O
,	O
Dispense	O
Quantity	O
:	O
90	O
vial	O
,	O
<EOS>	----
Refills	O
:	O
1	O
,	O
Entered	O
:	O
06	O
/	O
13	O
/	O
20	O
9	O
:	O
11	O
:	O
00	O
EDT	O
,	O
CarePlus	O
(	O
CVS	O
Specialty	O
)	O
#	O
2971	O
<EOS>	----
azithromycin	B-Antibiotic
200	O
mg	O
/	O
5	O
mL	O
oral	B-Therapeutic_or_Preventive_Procedure
liquid	I-Clinical_Drug
:	O
Dose	O
:	O
200	O
mg	O
,	O
Dose	O
Amount	O
:	O
5	O
mL	O
,	O
GTUBE	O
,	O
Mon	O
/	O
Wed	O
/	O
Fri	O
,	O
Dispense	O
Quantity	O
:	O
195	O
mL	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
06	O
/	O
13	O
/	O
20	O
9	O
:	O
11	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
aztreonam	B-Antibiotic
75	O
mg	O
inhalation	O
powder	I-Clinical_Drug
for	O
reconstitution	O
:	O
Dose	O
:	O
75	O
mg	O
,	O
INH	B-Antibiotic
,	O
TID	O
,	O
Special	O
Instructions	O
:	O
28	O
days	O
on	O
/	O
28	O
days	O
off	O
,	O
Dispense	O
Quantity	O
:	O
84	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
12	O
/	O
17	O
/	O
19	O
14	O
:	O
59	O
:	O
00	O
EST	O
,	O
CVS	O
SPECIALTY	O
Pharmacy	O
<EOS>	----
calcium	B-Pharmacologic_Substance
carbonate	I-Pharmacologic_Substance
1250	O
mg	O
/	O
5	O
mL	O
(	O
100	O
mg	O
/	O
mL	O
elemental	B-Pharmacologic_Substance
calcium	I-Pharmacologic_Substance
)	O
oral	B-Clinical_Drug
suspension	I-Clinical_Drug
:	O
Dose	O
:	O
625	O
mg	O
,	O
Dose	O
Amount	O
:	O
2.5	O
mL	O
,	O
GTUBE	O
,	O
daily	O
,	O
Special	O
Instructions	O
:	O
Separate	O
calcium	B-Pharmacologic_Substance
and	O
phos	B-CUI_less
suppl	O
by	O
at	O
least	O
2	O
hr	O
.	O
<EOS>	----
Incr	O
to	O
6mL	O
BIDx7d	O
beginning	O
AM	O
of	O
each	O
bisphosphonate	B-Pharmacologic_Substance
infusion	B-Therapeutic_or_Preventive_Procedure
,	O
Dispense	O
Quantity	O
:	O
500	O
mL	O
,	O
<EOS>	----
Refills	B-Therapeutic_or_Preventive_Procedure
:	O
11	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
12	O
:	O
30	O
:	O
0	O
...	O
<EOS>	----
cetirizine	B-Pharmacologic_Substance
1	O
mg	O
/	O
mL	O
oral	B-Clinical_Drug
syrup	I-Clinical_Drug
:	O
Dose	O
:	O
10	O
mg	O
,	O
Dose	O
Amount	O
:	O
10	O
mL	O
,	O
GTUBE	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
300	O
mL	O
,	O
Refills	O
:	O
4	O
,	O
Entered	O
:	O
06	O
/	O
10	O
/	O
20	O
15	O
:	O
33	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
cloBAZam	B-Pharmacologic_Substance
10	O
mg	O
oral	O
tablet	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
taken	O
with	O
liquid	O
am	O
doses	B-Quantitative_Concept
:	O
4	O
tabs	O
at	O
8.30pm	O
,	O
2	O
tabs	O
at	O
10	O
pm	O
,	O
-	O
per	O
G	O
tube	O
,	O
Dispense	O
Quantity	O
:	O
225	O
tab	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
06	O
/	O
09	O
/	O
20	O
17	O
:	O
58	O
:	O
00	O
EDT	O
,	O
Dispense	O
as	O
Written	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
cloNIDine	B-Pharmacologic_Substance
0.1	O
mg	O
oral	O
tablet	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
0.5	O
tab	O
/	O
50mcg	O
via	O
GTUBE	O
q	O
am	O
and	O
1	O
tab	O
/	O
100mcg	O
q	O
hs	O
,	O
as	O
needed	O
for	O
breakthrough	B-Qualitative_Concept
agitation	B-Sign_or_Symptom
or	O
insomnia	B-Sign_or_Symptom
.	O
90	O
day	O
suply	O
,	O
Dispense	O
Quantity	O
:	O
135	O
tab	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
08	O
/	O
04	O
/	O
20	O
9	O
:	O
38	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
diazePAM	B-Pharmacologic_Substance
5	O
mg	O
/	O
5	O
mL	O
oral	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
1	O
mg	O
,	O
Dose	O
Amount	O
:	O
1	O
mL	O
,	O
GTUBE	O
,	O
QID	O
,	O
Take	O
for	O
14	O
day	O
,	O
Special	O
Instructions	O
:	O
Please	O
take	O
Q6Hr	O
for	O
4	O
days	O
,	O
then	O
Q8Hr	O
for	O
3	O
days	O
,	O
then	O
Q12Hr	O
for	O
3	O
days	O
,	O
then	O
Q24Hr	O
for	O
3	O
days	O
,	O
Dispense	O
Quantity	O
:	O
56	O
mL	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
8	O
:	O
22	O
:	O
00	O
EDT	O
,	O
Stop	O
:	O
09	O
/	O
13	O
/	O
20	O
...	O
<EOS>	----
diclofenac	B-Clinical_Drug
1	I-Clinical_Drug
%	I-Clinical_Drug
topical	I-Clinical_Drug
gel	I-Clinical_Drug
:	O
Dose	O
:	O
2	O
g	O
,	O
TOP	O
,	O
QID	O
,	O
Dispense	O
Quantity	O
:	O
240	O
g	O
,	O
Entered	O
:	O
08	O
/	O
29	O
/	O
20	O
19	O
:	O
30	O
:	O
00	O
EDT	O
,	O
Stop	O
:	O
09	O
/	O
30	O
/	O
20	O
10	O
:	O
00	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
electrolyte	B-Therapeutic_or_Preventive_Procedure
replacement	I-Therapeutic_or_Preventive_Procedure
oral	I-Therapeutic_or_Preventive_Procedure
solution	I-Therapeutic_or_Preventive_Procedure
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
Give	O
450	O
ml	O
Pedialyte	B-Pharmacologic_Substance
mixed	O
with	O
21	O
grams	O
of	O
Beneprotein	B-Pharmacologic_Substance
and	O
1	O
/	O
4	O
tsp	O
Morton	B-Clinical_Drug
Lite	I-Clinical_Drug
salt	I-Clinical_Drug
an	O
give	O
in	O
50	O
ml	O
increments	O
by	O
J	B-Medical_Device
-	I-Medical_Device
tube	I-Medical_Device
through	O
the	O
day	O
.	O
,	O
Dispense	O
Quantity	O
:	O
14	O
,	O
000	O
mL	O
,	O
Refills	O
:	O
11	O
,	O
Entered	O
:	O
02	O
/	O
25	O
/	O
20	O
16	O
:	O
40	O
:	O
00	O
...	O
<EOS>	----
ergocalciferol	B-Pharmacologic_Substance
8000	O
intl	O
units	O
/	O
mL	O
oral	B-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
1	O
,	O
200	O
unit	O
,	O
Dose	O
Amount	O
:	O
0.15	O
mL	O
,	O
GTUBE	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
14	O
mL	O
,	O
Refills	O
:	O
0	O
,	O
Entered	O
:	O
01	O
/	O
27	O
/	O
20	O
17	O
:	O
03	O
:	O
00	O
EST	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
fluticasone	B-Pharmacologic_Substance
50	O
mcg	O
/	O
inh	I-Clinical_Drug
nasal	B-Clinical_Drug
spray	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
2	O
spray	O
,	O
Nasal	O
,	O
daily	O
,	O
PRN	O
Allergy	B-Sign_or_Symptom
symptoms	I-Sign_or_Symptom
,	O
Special	O
Instructions	O
:	O
each	O
nostril	O
,	O
Dispense	O
Quantity	O
:	O
1	O
EA	O
,	O
Refills	O
:	O
11	O
,	O
Entered	O
:	O
03	O
/	O
09	O
/	O
20	O
8	O
:	O
22	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
glycopyrrolate	B-Pharmacologic_Substance
1	O
mg	O
/	O
5	O
mL	O
oral	B-Clinical_Drug
solution	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
4	O
mL	O
GTUBE	B-Clinical_Drug
05	O
:	O
00	O
,	O
14	O
:	O
00	O
;	O
3.5	O
mL	O
20	O
:	O
00	O
.	O
<EOS>	----
Doses	O
may	O
be	O
reduced	O
,	O
or	O
completely	O
skipped	O
,	O
should	O
secretions	B-Body_Substance
be	O
thick	B-Qualitative_Concept
,	O
tenacious	B-CUI_less
,	O
or	O
difficult	O
to	O
extricate	O
.	O
,	O
Dispense	O
Quantity	O
:	O
900	O
mL	O
,	O
<EOS>	----
Refills	B-Therapeutic_or_Preventive_Procedure
:	O
3	O
,	O
Entered	O
:	O
09	O
/	O
02	O
/	O
20	O
8	O
:	O
...	O
<EOS>	----
hydrocortisone	B-Pharmacologic_Substance
5	O
mg	O
oral	O
tablet	O
:	O
Dose	O
:	O
15	O
mg	O
,	O
Dose	O
Amount	O
:	O
3	O
tab	O
,	O
GTUBE	O
,	O
Q6hr	O
,	O
Special	O
Instructions	O
:	O
give	O
as	O
directed	O
for	O
stress	B-CUI_less
e.g.	O
,	O
fever	B-Sign_or_Symptom
>	I-CUI_less
101F	I-CUI_less
,	O
diarrhea	B-Sign_or_Symptom
,	O
broken	B-Finding
bone	I-Finding
,	O
infection	B-Disease_or_Syndrome
,	O
etc	O
.	O
,	O
Dispense	O
Quantity	O
:	O
150	O
tab	O
,	O
Refills	O
:	O
11	O
,	O
Entered	O
:	O
10	O
/	O
03	O
/	O
19	O
13	O
:	O
44	O
:	O
09	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
hyoscyamine	B-Pharmacologic_Substance
0.125	O
mg	O
sublingual	I-Clinical_Drug
tablet	I-Clinical_Drug
:	O
Dose	O
:	O
0.25	O
mg	O
,	O
Dose	O
Amount	O
:	O
2	O
tab	O
,	O
SL	O
,	O
Q4hr	O
,	O
PRN	O
Agitation	B-Sign_or_Symptom
,	O
Dispense	O
Quantity	O
:	O
60	O
cap	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
05	O
/	O
14	O
/	O
20	O
12	O
:	O
24	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
,	O
40.7	O
<EOS>	----
ipratropium	B-Pharmacologic_Substance
42	O
mcg	O
/	O
inh	O
(	O
0.06	O
%	O
)	O
nasal	B-Clinical_Drug
spray	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
2	O
spray	O
,	O
Nasal	O
,	O
TID	O
,	O
Dispense	O
Quantity	O
:	O
3	O
EA	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
01	O
/	O
07	O
/	O
20	O
13	O
:	O
05	O
:	O
00	O
EST	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
ipratropium	B-Pharmacologic_Substance
500	O
mcg	O
/	O
2.5	O
mL	O
inhalation	B-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
500	O
mcg	O
,	O
Dose	O
Amount	O
:	O
2.5	O
mL	O
,	O
NEB	O
,	O
TID	O
,	O
Dispense	O
Quantity	O
:	O
675	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
01	O
/	O
07	O
/	O
20	O
13	O
:	O
05	O
:	O
00	O
EST	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
lacosamide	B-Pharmacologic_Substance
10	O
mg	O
/	O
mL	O
oral	O
solution	I-Clinical_Drug
:	O
Dose	O
:	O
100	O
mg	O
,	O
Dose	O
Amount	O
:	O
10	O
mL	O
,	O
GTUBE	O
,	O
BID	O
,	O
Dispense	O
Quantity	O
:	O
600	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
10	O
:	O
58	O
:	O
00	O
EDT	O
<EOS>	----
lactobacillus	B-Antibiotic
rhamnosus	I-Antibiotic
GG	I-Clinical_Drug
oral	I-Clinical_Drug
capsule	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
1	O
cap	O
,	O
GTUBE	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
30	O
cap	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
08	O
/	O
05	O
/	O
20	O
16	O
:	O
25	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
levOCARNitine	B-Pharmacologic_Substance
100	O
mg	O
/	O
mL	O
oral	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
500	O
mg	O
,	O
Dose	O
Amount	O
:	O
5	O
mL	O
,	O
GTUBE	O
,	O
TID	O
,	O
Dispense	O
Quantity	O
:	O
1350	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
06	O
/	O
09	O
/	O
20	O
17	O
:	O
58	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
levalbuterol	B-Pharmacologic_Substance
0.63	O
mg	O
/	O
3	O
mL	O
inhalation	B-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
0.63	O
mg	O
,	O
Dose	O
Amount	O
:	O
3	O
mL	O
,	O
INH	B-Antibiotic
,	O
Q8hr	O
,	O
PRN	O
Respiratory	B-Sign_or_Symptom
Distress	I-Sign_or_Symptom
,	O
Dispense	O
Quantity	O
:	O
810	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
03	O
/	O
09	O
/	O
20	O
10	O
:	O
08	O
:	O
32	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
levothyroxine	B-Pharmacologic_Substance
88	O
mcg	O
(	O
0.088	O
mg	O
)	O
oral	O
tablet	O
:	O
Dose	O
:	O
88	O
mcg	O
,	O
Dose	O
Amount	O
:	O
1	O
tab	O
,	O
GTUBE	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
30	O
tab	O
,	O
Refills	O
:	O
11	O
,	O
Entered	O
:	O
05	O
/	O
22	O
/	O
20	O
13	O
:	O
56	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
lidocaine	B-Clinical_Drug
5	I-Clinical_Drug
%	I-Clinical_Drug
topical	I-Clinical_Drug
film	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
1	O
patch	O
,	O
TD	O
,	O
Q24hr	O
,	O
PRN	O
Pain	B-Sign_or_Symptom
:	O
Anticip	O
/	O
Mild	O
/	O
Mod	O
(	O
Score	O
0	O
-	O
6	O
)	O
,	O
Special	O
Instructions	O
:	O
remove	O
patches	O
after	O
12	O
hours	O
,	O
Dispense	O
Quantity	O
:	O
30	O
patch	O
,	O
Entered	O
:	O
09	O
/	O
03	O
/	O
20	O
9	O
:	O
36	O
:	O
00	O
EDT	O
,	O
Stop	O
:	O
10	O
/	O
10	O
/	O
20	O
9	O
:	O
36	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
midazolam	B-Pharmacologic_Substance
5	O
mg	O
/	O
mL	O
injectable	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
Give	O
0.8	O
mL	O
(	O
4	O
mg	O
)	O
to	O
EACH	O
nostril	O
OR	O
1.6	O
mL	O
(	O
8	O
mg	O
)	O
in	O
the	O
buccal	O
cavity	O
for	O
convulsive	B-Sign_or_Symptom
seizure	I-Finding
lasting	O
>	O
3	O
minutes	O
,	O
Dispense	O
Quantity	O
:	O
2	O
EA	O
,	O
Refills	O
:	O
2	O
,	O
Entered	O
:	O
08	O
/	O
04	O
/	O
20	O
16	O
:	O
48	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
midazolam	B-Pharmacologic_Substance
5	O
mg	O
/	O
mL	O
injectable	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
Give	O
0.8	O
mL	O
(	O
4	O
mg	O
)	O
to	O
EACH	O
nostril	O
OR	O
1.6	O
mL	O
(	O
8	O
mg	O
)	O
in	O
the	O
buccal	O
cavity	O
for	O
convulsive	B-Sign_or_Symptom
seizure	I-Finding
lasting	O
>	O
3	O
minutes	O
,	O
Dispense	O
Quantity	O
:	O
2	O
EA	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
08	O
/	O
13	O
/	O
20	O
8	O
:	O
27	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
nystatin	B-Antibiotic
-	O
triamcinolone	B-Pharmacologic_Substance
100	O
,	O
000	O
units	O
/	O
g	O
-	O
0.1	O
%	I-Clinical_Drug
topical	B-Clinical_Drug
cream	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
1	O
appl	O
,	O
TOP	O
,	O
BID	O
,	O
Special	O
Instructions	O
:	O
Apply	O
think	B-Clinical_Drug
layer	I-Clinical_Drug
to	O
GJ	B-Medical_Device
tube	I-Medical_Device
site	B-Spatial_Concept
BID	O
.	O
<EOS>	----
Discontinue	O
when	O
rash	B-Sign_or_Symptom
resolves	O
.	O
<EOS>	----
Do	O
not	O
use	O
longer	O
than	O
25	O
days	O
.	O
,	O
Dispense	O
Quantity	O
:	O
30	O
g	O
,	O
<EOS>	----
Refills	O
:	O
1	O
,	O
Entered	O
:	O
05	O
/	O
13	O
/	O
20	O
8	O
:	O
54	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
,	O
40.7	O
<EOS>	----
omega	B-Pharmacologic_Substance
-	I-Pharmacologic_Substance
3	I-Pharmacologic_Substance
polyunsaturated	I-Pharmacologic_Substance
fatty	I-Pharmacologic_Substance
acids	I-Pharmacologic_Substance
1400	O
mg	O
/	O
5	O
mL	O
oral	O
liquid	I-Clinical_Drug
:	O
Dose	O
:	O
700	O
mg	O
,	O
Dose	O
Amount	O
:	O
2.5	O
mL	O
,	O
PO	O
,	O
daily	O
,	O
Dispense	O
Quantity	O
:	O
210	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
05	O
/	O
15	O
/	O
19	O
16	O
:	O
05	O
:	O
27	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
omeprazole	B-Pharmacologic_Substance
2	O
mg	O
/	O
mL	O
oral	I-Clinical_Drug
suspension	I-Clinical_Drug
:	O
Dose	O
:	O
20	O
mg	O
,	O
Dose	O
Amount	O
:	O
10	O
mL	O
,	O
GTUBE	O
,	O
daily	O
,	O
Special	O
Instructions	O
:	O
Give	O
at	O
bedtime	O
,	O
Dispense	O
Quantity	O
:	O
600	O
mL	O
,	O
Refills	O
:	O
3	O
,	O
Entered	O
:	O
05	O
/	O
07	O
/	O
20	O
16	O
:	O
20	O
:	O
00	O
EDT	O
,	O
ACC	O
Apothecary	O
<EOS>	----
ondansetron	B-Pharmacologic_Substance
4	O
mg	O
/	O
5	O
mL	O
oral	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
4	O
mg	O
,	O
PO	O
,	O
Q8hr	O
,	O
PRN	O
Nausea	B-Sign_or_Symptom
/	O
Vomiting	B-Sign_or_Symptom
,	O
Dispense	O
Quantity	O
:	O
90	O
mL	O
,	O
Refills	O
:	O
0	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
11	O
:	O
02	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
senna	B-Pharmacologic_Substance
8.8	O
mg	O
/	O
5	O
mL	O
oral	B-Clinical_Drug
syrup	I-Clinical_Drug
:	O
Dose	O
:	O
19.36	O
mg	O
,	O
Dose	O
Amount	O
:	O
11	O
mL	O
,	O
GTUBE	O
,	O
daily	O
,	O
Special	O
Instructions	O
:	O
Indication	O
more	O
than	O
6yrs	O
old	O
,	O
Dispense	O
Quantity	O
:	O
660	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
05	O
/	O
07	O
/	O
20	O
14	O
:	O
00	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
sodium	B-Pharmacologic_Substance
chloride	I-Pharmacologic_Substance
0.9	O
%	O
inhalation	I-Clinical_Drug
solution	I-Clinical_Drug
:	O
Dose	O
:	O
0.027	O
g	O
,	O
Dose	O
Amount	O
:	O
3	O
mL	O
,	O
INH	B-Antibiotic
,	O
Q3hr	O
,	O
PRN	O
Congestion	B-Sign_or_Symptom
,	O
Special	O
Instructions	O
:	O
9	O
boxes	O
-	O
90	O
da	O
,	O
Dispense	O
Quantity	O
:	O
9	O
kit	O
,	O
Refills	O
:	O
1	O
,	O
Entered	O
:	O
06	O
/	O
13	O
/	O
20	O
9	O
:	O
11	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
tetrabenazine	B-Pharmacologic_Substance
12.5	O
mg	O
oral	O
tablet	O
:	O
Dose	O
:	O
12.5	O
mg	O
,	O
Dose	O
Amount	O
:	O
1	O
tab	O
,	O
GTUBE	O
,	O
BID	O
,	O
Dispense	O
Quantity	O
:	O
60	O
tab	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
09	O
/	O
03	O
/	O
20	O
10	O
:	O
59	O
:	O
00	O
EDT	O
<EOS>	----
zolpidem	B-Pharmacologic_Substance
3.5	O
mg	O
sublingual	B-Clinical_Drug
tablet	I-Clinical_Drug
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
1	O
tab	O
SL	O
as	O
needed	O
for	O
sleep	O
,	O
Dispense	O
Quantity	O
:	O
12	O
tab	O
,	O
Entered	O
:	O
06	O
/	O
15	O
/	O
20	O
12	O
:	O
50	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
0130	O
<EOS>	----
zonisamide	B-Pharmacologic_Substance
10	O
mg	O
/	O
mL	O
oral	B-Therapeutic_or_Preventive_Procedure
Liq	B-Clinical_Drug
(	O
compound	O
)	O
:	O
See	O
Instructions	O
,	O
Special	O
Instructions	O
:	O
35ml	O
pgt	O
QPM	O
,	O
Dispense	O
Quantity	O
:	O
1	O
,	O
050	O
mL	O
,	O
Refills	O
:	O
5	O
,	O
Entered	O
:	O
07	O
/	O
08	O
/	O
20	O
12	O
:	O
12	O
:	O
00	O
EDT	O
,	O
CVS	O
/	O
pharmacy	O
#	O
2162	O
<EOS>	----
Documented	O
Medications	O
<EOS>	----
Documented	O
<EOS>	----
Fleet	B-Clinical_Drug
Glycerin	I-Clinical_Drug
Suppositories	I-Clinical_Drug
Pediatric	O
:	O
PR	O
,	O
daily	O
,	O
Entered	O
:	O
10	O
/	O
21	O
/	O
19	O
12	O
:	O
34	O
:	O
14	O
EDT	O
<EOS>	----
Multiple	B-Quantitative_Concept
Vitamins	B-Clinical_Drug
with	I-Clinical_Drug
Minerals	I-Clinical_Drug
oral	I-Clinical_Drug
tablet	I-Clinical_Drug
,	O
chewable	O
:	O
GTUBE	O
,	O
daily	O
,	O
Entered	O
:	O
09	O
/	O
20	O
/	O
19	O
7	O
:	O
21	O
:	O
47	O
EDT	O
<EOS>	----
Vitamin	B-Pharmacologic_Substance
C	I-Pharmacologic_Substance
:	O
Dose	O
:	O
300	O
mg	O
,	O
GTUBE	O
,	O
daily	O
,	O
Entered	O
:	O
05	O
/	O
29	O
/	O
15	O
9	O
:	O
21	O
:	O
17	O
EDT	O
<EOS>	----
konsyl	B-Pharmacologic_Substance
2	O
tsp	O
in	O
pedialyte	O
and	O
1	O
/	O
4	O
tsp	O
lite	O
morton	O
salt	O
:	O
konsyl	B-Pharmacologic_Substance
2	O
tsp	O
in	O
pedialyte	O
and	O
1	O
/	O
4	O
tsp	O
lite	O
morton	O
salt	O
,	O
Entered	O
:	O
08	O
/	O
17	O
/	O
17	O
15	O
:	O
11	O
:	O
00	O
EDT	O
<EOS>	----
pyridoxine	B-Pharmacologic_Substance
:	O
Dose	O
:	O
100	O
mg	O
,	O
Dose	O
Amount	O
:	O
1	O
mL	O
,	O
PO	O
,	O
daily	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
6	O
:	O
37	O
:	O
00	O
EDT	O
<EOS>	----
riboflavin	B-Pharmacologic_Substance
50	O
mg	O
oral	O
tablet	O
:	O
Dose	O
:	O
12.5	O
mg	O
,	O
Dose	O
Amount	O
:	O
0.25	O
tab	O
,	O
GTUBE	O
,	O
Q12hr	O
,	O
Entered	O
:	O
08	O
/	O
30	O
/	O
20	O
6	O
:	O
37	O
:	O
00	O
EDT	O
<EOS>	----
saliva	B-Clinical_Drug
substitutes	I-Clinical_Drug
:	O
Dose	O
Amount	O
:	O
15	O
mL	O
,	O
Swish	O
and	O
Spit	O
,	O
5x	O
/	O
Day	O
,	O
Entered	O
:	O
09	O
/	O
20	O
/	O
19	O
7	O
:	O
24	O
:	O
48	O
EDT	O
<EOS>	----
selenium	B-Pharmacologic_Substance
:	O
Dose	O
:	O
25	O
mcg	O
,	O
GTUBE	O
,	O
daily	O
,	O
Entered	O
:	O
09	O
/	O
19	O
/	O
19	O
2	O
:	O
25	O
:	O
20	O
EDT	O
<EOS>	----
zoledronic	B-Pharmacologic_Substance
acid	I-Pharmacologic_Substance
4	O
mg	O
/	O
100	O
mL	O
intravenous	O
solution	I-Clinical_Drug
:	O
IV	O
,	O
Entered	O
:	O
10	O
/	O
21	O
/	O
19	O
15	O
:	O
00	O
:	O
57	O
EDT	O
.	O
<EOS>	----
Immunizations	O
:	O
Up	O
to	O
date	O
.	O
<EOS>	----
Past	O
Medical	O
/	O
Family	O
/	O
Social	O
History	O
<EOS>	----
Medical	O
history	O
<EOS>	----
reviewed	O
in	O
chart	O
and	O
non	O
-	O
contributory	O
to	O
the	O
patient	O
's	O
presentation	O
except	O
as	O
noted	O
above	O
in	O
the	O
HPI	O
.	O
<EOS>	----
Surgical	O
history	O
:	O
reviewed	O
in	O
chart	O
and	O
non	O
-	O
contributory	O
to	O
the	O
patient	O
's	O
presentation	O
except	O
as	O
noted	O
above	O
in	O
the	O
HPI	O
.	O
<EOS>	----
Family	O
history	O
:	O
Reviewed	O
and	O
non	O
-	O
contributory	O
to	O
the	O
patient	O
's	O
condition	O
..	O
<EOS>	----
Social	O
history	O
:	O
Lives	O
at	O
home	O
with	O
family	O
..	O
<EOS>	----
Problem	O
list	O
:	O
<EOS>	----
All	O
Problems	O
(	O
Selected	O
)	O
<EOS>	----
Acquired	B-Pathologic_Function
scoliosis	I-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
178485010	O
/	O
Confirmed	O
<EOS>	----
Adrenal	B-Disease_or_Syndrome
insufficiency	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
1491625012	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Anisocoria	B-Pathologic_Function
/	O
SNOMED	O
CT	O
22334011	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Aspiration	B-Therapeutic_or_Preventive_Procedure
into	O
trachea	I-Injury_or_Poisoning
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2791768012	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Ballismus	O
.	O
/	O
SNOMED	O
CT	O
2674578015	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Bone	B-Finding
density	I-Finding
low	B-Qualitative_Concept
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2912617014	O
/	O
Confirmed	O
<EOS>	----
Chorea	B-Disease_or_Syndrome
.	O
/	O
SNOMED	O
CT	O
406579018	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Chronic	B-Sign_or_Symptom
constipation	I-Sign_or_Symptom
/	O
SNOMED	O
CT	O
353853017	O
/	O
Confirmed	O
<EOS>	----
Chronic	B-Disease_or_Syndrome
lung	I-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2535179019	O
/	O
Confirmed	O
<EOS>	----
Cortical	B-Pathologic_Function
blindness	I-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
113901010	O
/	O
Confirmed	O
<EOS>	----
Curvature	B-Organ_or_Tissue_Function
of	O
spine	B-Body_Location_or_Region
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
106745019	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Dependence	O
on	O
wheel	O
chair	O
/	O
SNOMED	O
CT	O
2693235012	O
/	O
Confirmed	O
<EOS>	----
Developmental	B-Finding
delay	I-Finding
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
370667011	O
/	O
Confirmed	O
<EOS>	----
Disorder	B-Finding
of	I-Finding
bone	I-Finding
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2474921010	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Epistaxis	B-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
21406015	O
/	O
Confirmed	O
<EOS>	----
Esotropia	B-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	O
28071010	O
/	O
Confirmed	O
<EOS>	----
Gastroesophageal	B-Disease_or_Syndrome
reflux	I-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
353135014	O
/	O
Confirmed	O
<EOS>	----
Global	B-Pathologic_Function
developmental	I-Finding
delay	I-Finding
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
338115019	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Hashimoto	B-Disease_or_Syndrome
thyroiditis	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
36884017	O
/	O
Confirmed	O
<EOS>	----
History	O
of	O
immune	B-Disease_or_Syndrome
thrombocytopenia	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
2816356014	O
/	O
Confirmed	O
<EOS>	----
Hypothyroidism	B-Disease_or_Syndrome
due	O
to	O
Hashimoto	B-Disease_or_Syndrome
's	I-Disease_or_Syndrome
thyroiditis	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
355967011	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Hypoventilation	B-Pathologic_Function
during	O
sleep	O
due	O
to	O
neuromuscular	B-Disease_or_Syndrome
disorder	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2695538012	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Hypoxia	B-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
1483143019	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Idiopathic	B-Disease_or_Syndrome
osteoporosis	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
6641011	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Jejunostomy	B-Medical_Device
tube	I-Medical_Device
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
3059018	O
/	O
Confirmed	O
<EOS>	----
Long	O
-	O
term	O
drug	B-Therapeutic_or_Preventive_Procedure
therapy	I-Therapeutic_or_Preventive_Procedure
/	O
SNOMED	B-Diagnostic_Procedure
CT	O
397160018	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Mitochondrial	B-Pathologic_Function
cytopathy	I-Pathologic_Function
/	O
SNOMED	O
CT	O
359707011	O
/	O
Confirmed	O
<EOS>	----
Mitochondrial	B-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
2871257019	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Mitochondrial	B-Disease_or_Syndrome
myopathy	I-Disease_or_Syndrome
/	O
SNOMED	O
CT	O
28528010	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
OSA	B-Disease_or_Syndrome
-	O
Obstructive	B-Disease_or_Syndrome
sleep	I-Disease_or_Syndrome
apnea	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
1218438013	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Osteopenia	B-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
456694019	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Osteoporosis	B-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
107806013	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Paroxysmal	B-Disease_or_Syndrome
choreoathetosis	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
83196018	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Phimosis	O
/	O
SNOMED	O
CT	O
2912847013	O
/	O
Confirmed	O
<EOS>	----
Poor	B-Finding
muscle	I-Finding
tone	I-Finding
/	O
SNOMED	O
CT	O
1777712016	O
/	O
Confirmed	O
<EOS>	----
Recurrent	B-Temporal_Concept
bronchiectasis	B-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
301524014	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Restrictive	B-Disease_or_Syndrome
lung	I-Disease_or_Syndrome
disease	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
60901014	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Scoliosis	B-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
480879017	O
/	O
Confirmed	O
<EOS>	----
Secondary	B-Disease_or_Syndrome
adrenal	I-Disease_or_Syndrome
insufficiency	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
3013428016	O
/	O
Confirmed	O
<EOS>	----
Seizure	B-Finding
disorder	I-Finding
/	O
SNOMED	O
CT	O
206998011	O
/	O
Confirmed	O
<EOS>	----
Sleep	B-Finding
disorder	I-Finding
/	O
SNOMED	O
CT	O
67285010	O
/	O
Confirmed	O
<EOS>	----
Swallowing	B-Finding
problem	I-Finding
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
1778582014	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Thrombocytopenia	B-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
1227080015	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Urinary	B-Pathologic_Function
retention	I-Pathologic_Function
/	O
SNOMED	B-Diagnostic_Procedure
CT	O
397939011	O
/	O
Confirmed	O
<EOS>	----
Added	O
by	O
QCC	O
<EOS>	----
Voiding	B-Disease_or_Syndrome
dysfunction	I-Disease_or_Syndrome
/	O
SNOMED	B-Diagnostic_Procedure
CT	I-Diagnostic_Procedure
2920384011	O
/	O
Confirmed	O
.	O
<EOS>	----
Physical	O
Examination	O
<EOS>	----
Vital	O
signs	O
:	O
Vital	O
Signs	O
<EOS>	----
9	O
/	O
12	O
/	O
2020	O
19	O
:	O
55	O
EDT	O
<EOS>	----
Temperature	O
<EOS>	----
36.6	O
DegC	O
<EOS>	----
Temperature	O
Route	O
<EOS>	----
Temporal	O
artery	O
<EOS>	----
Heart	B-Health_Care_Activity
Rate	I-Health_Care_Activity
<EOS>	----
125	O
bpm	O
HI	B-Qualitative_Concept
<EOS>	----
Pulse	O
Source	O
<EOS>	----
Apical	O
<EOS>	----
Respiratory	B-Health_Care_Activity
Rate	I-Health_Care_Activity
<EOS>	----
18	O
br	O
/	O
min	O
<EOS>	----
9	O
/	O
12	O
/	O
2020	O
17	O
:	O
47	O
EDT	O
<EOS>	----
Temperature	O
<EOS>	----
36.3	O
DegC	O
LOW	O
<EOS>	----
Systolic	B-Health_Care_Activity
Blood	I-Health_Care_Activity
Pressure	I-Health_Care_Activity
<EOS>	----
119	O
mmHg	O
<EOS>	----
Temperature	O
Route	O
<EOS>	----
Temporal	O
artery	O
<EOS>	----
Diastolic	B-Health_Care_Activity
Blood	I-Health_Care_Activity
Pressure	I-Health_Care_Activity
<EOS>	----
93	O
mmHg	O
HI	B-Pathologic_Function
<EOS>	----
Heart	B-Health_Care_Activity
Rate	I-Health_Care_Activity
<EOS>	----
130	O
bpm	O
HI	B-Qualitative_Concept
<EOS>	----
Pulse	O
Source	O
<EOS>	----
Apical	O
<EOS>	----
Respiratory	B-Health_Care_Activity
Rate	I-Health_Care_Activity
<EOS>	----
16	O
br	O
/	O
min	O
<EOS>	----
Blood	B-CUI_less
Pressure	I-CUI_less
Category	I-CUI_less
<EOS>	----
Stage	B-Disease_or_Syndrome
2	I-Disease_or_Syndrome
Hypertension	I-Disease_or_Syndrome
<EOS>	----
Blood	B-Diagnostic_Procedure
Pressure	I-Diagnostic_Procedure
Method	I-Diagnostic_Procedure
<EOS>	----
Automated	O
<EOS>	----
Blood	O
Pressure	I-CUI_less
Location	O
<EOS>	----
RUE	O
<EOS>	----
Vital	O
Signs	O
Posture	O
<EOS>	----
Sitting	O
<EOS>	----
Oxygen	B-Laboratory_Procedure
Saturation	I-Laboratory_Procedure
(	O
SPO2	B-Laboratory_Procedure
)	O
<EOS>	----
98	O
%	O
<EOS>	----
Oxygen	O
Source	O
<EOS>	----
Room	O
air	O
<EOS>	----
Vital	O
Signs	O
Information	O
<EOS>	----
moving	O
right	O
arm	O
during	O
BP	B-Health_Care_Activity
<EOS>	----
General	O
:	O
Alert	O
<EOS>	----
Skin	O
:	O
Warm	O
.	O
dry	O
.	O
<EOS>	----
Head	O
:	O
Normocephalic	O
.	O
atraumatic	B-CUI_less
.	O
<EOS>	----
Neck	O
:	O
Supple	O
<EOS>	----
Eye	O
:	O
Pupils	O
are	O
equal	O
,	O
round	O
and	O
reactive	O
to	O
light	O
.	O
extraocular	O
movements	O
are	O
intact	O
.	O
<EOS>	----
Cardiovascular	O
:	O
Regular	O
rate	O
and	O
rhythm	O
<EOS>	----
Respiratory	O
:	O
Lungs	O
are	O
clear	O
to	O
auscultation	B-Diagnostic_Procedure
<EOS>	----
Gastrointestinal	O
:	O
Soft	O
.	O
<EOS>	----
Non	B-Finding
distended	I-Finding
.	O
<EOS>	----
Normal	O
bowel	O
sounds	O
.	O
<EOS>	----
G	B-Medical_Device
tube	I-Medical_Device
in	O
place	O
c	O
/	O
d	O
/	O
i	O
.	O
<EOS>	----
Medical	O
Decision	O
Making	O
<EOS>	----
13	O
yo	O
M	O
w	O
/	O
complex	O
medical	O
history	O
here	O
with	O
persistent	B-Temporal_Concept
tachycardia	B-Finding
since	O
spinal	B-Therapeutic_or_Preventive_Procedure
fusion	I-Therapeutic_or_Preventive_Procedure
surgery	I-Therapeutic_or_Preventive_Procedure
one	O
month	O
ago	O
.	O
<EOS>	----
Afebrile	B-Finding
,	O
satting	B-Laboratory_Procedure
100	O
%	O
on	O
RA	B-Spatial_Concept
,	O
no	O
focal	B-Spatial_Concept
source	B-Finding
of	I-Finding
infection	I-Finding
on	O
exam	B-Health_Care_Activity
.	O
<EOS>	----
Ddx	B-CUI_less
PE	B-Disease_or_Syndrome
,	O
UTI	B-Disease_or_Syndrome
,	O
pain	B-Sign_or_Symptom
,	O
PNA	B-Disease_or_Syndrome
,	O
abscess	B-Disease_or_Syndrome
,	O
hematoma	B-Pathologic_Function
.	O
<EOS>	----
Will	O
obtain	O
labs	B-Laboratory_Procedure
,	O
CXR	B-Diagnostic_Procedure
,	O
abd	B-Diagnostic_Procedure
XR	I-Diagnostic_Procedure
,	O
abd	B-Diagnostic_Procedure
US	I-Diagnostic_Procedure
,	O
and	O
consult	O
ortho	O
.	O
<EOS>	----
Results	O
review	O
:	O
Lab	O
results	O
:	O
Lab	O
View	O
<EOS>	----
9	O
/	O
12	O
/	O
2020	O
21	O
:	O
40	O
EDT	O
<EOS>	----
WBC	B-Laboratory_Procedure
<EOS>	----
6.58	O
K	B-Laboratory_Procedure
cells	I-Laboratory_Procedure
/	O
uL	I-Laboratory_Procedure
<EOS>	----
Hemoglobin	B-Laboratory_Procedure
<EOS>	----
12.8	O
g	O
/	O
dL	O
<EOS>	----
Hematocrit	B-Laboratory_Procedure
<EOS>	----
39.5	O
%	O
<EOS>	----
Platelet	O
<EOS>	----
200	O
K	O
cells	O
/	O
uL	O
<EOS>	----
Sodium	B-Pharmacologic_Substance
<EOS>	----
141	O
mmol	O
/	O
L	O
<EOS>	----
Potassium	B-Laboratory_Procedure
<EOS>	----
4.19	O
mmol	O
/	O
L	O
<EOS>	----
Chloride	B-Laboratory_Procedure
<EOS>	----
105	O
mmol	O
/	O
L	O
<EOS>	----
CO2	B-Laboratory_Procedure
<EOS>	----
24	O
mmol	O
/	O
L	O
<EOS>	----
Anion	B-Laboratory_Procedure
Gap	I-Laboratory_Procedure
<EOS>	----
12.0	O
mmol	O
/	O
L	O
<EOS>	----
BUN	B-Laboratory_Procedure
<EOS>	----
11	O
mg	O
/	O
dL	O
<EOS>	----
Creatinine	B-Laboratory_Procedure
<EOS>	----
0.25	O
mg	O
/	O
dL	O
LOW	B-Qualitative_Concept
<EOS>	----
CK	B-Laboratory_Procedure
<EOS>	----
72	O
unit	O
/	O
L	O
<EOS>	----
C	B-Laboratory_Procedure
-	I-Laboratory_Procedure
Reactive	I-Laboratory_Procedure
Protein	I-Laboratory_Procedure
<EOS>	----
0.33	O
mg	O
/	O
dL	O
<EOS>	----
Specific	B-Finding
Gravity	I-Finding
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
1.009	O
<EOS>	----
Protein	B-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
Negative	O
<EOS>	----
Blood	B-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
Negative	O
<EOS>	----
Leukocytes	B-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
2	O
+	O
<EOS>	----
Nitrite	B-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
Negative	O
<EOS>	----
White	B-Laboratory_Procedure
Cells	I-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
52	O
/hpf	O
HI	B-Pathologic_Function
<EOS>	----
Red	B-Laboratory_Procedure
Cells	I-Laboratory_Procedure
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
<	O
1	O
/hpf	O
<EOS>	----
Bacteria	B-Bacterium
,	O
Urinalysis	B-Laboratory_Procedure
<EOS>	----
Trace	O
graded	O
/	O
hpf	O
<EOS>	----
SARS	B-Disease_or_Syndrome
CoV	I-Laboratory_Procedure
-	I-Diagnostic_Procedure
2	I-Diagnostic_Procedure
(	O
COVID	B-CUI_less
-	O
19	O
)	O
PCR	B-Diagnostic_Procedure
,	O
Resp	O
,	O
QuaL	O
<EOS>	----
Negative	O
<EOS>	----
Anti	B-Laboratory_Procedure
-	O
SARS	B-Disease_or_Syndrome
-	I-Disease_or_Syndrome
CoV	I-Disease_or_Syndrome
-	O
2	O
<EOS>	----
Non	O
-	O
reactive	O
<EOS>	----
Radiology	O
results	O
:	O
Xray	B-Diagnostic_Procedure
spine	I-Diagnostic_Procedure
:	O
IMPRESSION	O
:	O
Diffuse	B-Spatial_Concept
demineralization	B-Pathologic_Function
of	O
the	O
thoracic	B-Body_Part,_Organ,_or_Organ_Component
spine	I-Body_Part,_Organ,_or_Organ_Component
.	O
No	O
acute	B-Qualitative_Concept
<EOS>	----
fracture	B-Injury_or_Poisoning
of	I-Finding
the	I-Finding
thoracic	I-Injury_or_Poisoning
spine	I-Body_Part,_Organ,_or_Organ_Component
visualized	O
.	O
<EOS>	----
CXR	B-Diagnostic_Procedure
:	O
IMPRESSION	O
:	O
Similar	O
minimal	B-Qualitative_Concept
left	B-Spatial_Concept
infrahilar	I-Body_Location_or_Region
subsegmental	B-Body_Location_or_Region
atelectasis	B-Pathologic_Function
.	O
No	O
new	B-Qualitative_Concept
focal	B-Spatial_Concept
<EOS>	----
consolidation	B-Qualitative_Concept
.	O
<EOS>	----
Abd	O
XR	B-Diagnostic_Procedure
:	O
IMPRESSION	O
:	O
<EOS>	----
Nonobstructed	B-Pathologic_Function
,	O
nonspecific	B-Qualitative_Concept
bowel	B-Finding
gas	I-Finding
pattern	I-Finding
with	O
large	B-Quantitative_Concept
stool	B-Laboratory_or_Test_Result
burden	I-Laboratory_or_Test_Result
.	O
<EOS>	----
Expected	O
,	O
similar	O
position	O
of	O
the	B-Medical_Device
gastrojejunostomy	I-Medical_Device
tube	I-Medical_Device
.	O
<EOS>	----
Abd	B-Diagnostic_Procedure
US	I-Diagnostic_Procedure
:	O
1.Slightly	O
limited	B-Qualitative_Concept
exam	B-Health_Care_Activity
secondary	O
to	O
body	O
positioning	O
.	O
<EOS>	----
2.Normal	O
sonographic	O
appearance	O
of	O
the	O
kidneys	O
.	O
<EOS>	----
3.No	O
focal	B-Spatial_Concept
fluid	B-Pathologic_Function
collection	I-Pathologic_Function
or	O
thickened	B-Finding
bowel	I-Finding
loops	I-Finding
seen	O
in	O
the	O
<EOS>	----
abdomen	O
.	O
<EOS>	----
4.Laminar	O
fluid	I-Pathologic_Function
collection	I-Pathologic_Function
deep	O
to	O
the	O
posterior	B-Spatial_Concept
midline	B-Spatial_Concept
incision	B-Spatial_Concept
site	I-Spatial_Concept
<EOS>	----
without	O
associated	B-Qualitative_Concept
hyperemia	B-Finding
.	O
This	O
may	O
reflect	O
a	O
postoperative	B-Temporal_Concept
seroma	B-Pathologic_Function
..	O
<EOS>	----
Reexamination	O
/	O
Reevaluation	O
<EOS>	----
22	O
:	O
56	O
UTI	B-Disease_or_Syndrome
with	O
2	O
+	O
LE	B-Laboratory_Procedure
,	O
52	O
WBC	B-Laboratory_Procedure
.	O
CBC	B-Laboratory_Procedure
,	O
BMP	B-Laboratory_Procedure
nl	O
.	O
<EOS>	----
Will	O
treat	O
with	O
ceftriaxone	B-Antibiotic
for	O
UTI	B-Disease_or_Syndrome
.	O
<EOS>	----
Mom	O
comfortable	O
with	O
going	O
home	O
if	O
remainder	O
of	O
workup	B-CUI_less
is	O
negative	O
with	O
outpatient	O
followup	O
.	O
<EOS>	----
23	O
:	O
57	O
Per	O
ortho	O
,	O
incision	B-Therapeutic_or_Preventive_Procedure
c	O
/	O
d	O
/	O
i	O
,	O
ok	O
to	O
dc	O
home	O
on	O
PO	B-Therapeutic_or_Preventive_Procedure
antibiotics	B-Antibiotic
if	O
remainder	O
of	O
workup	B-CUI_less
neg	O
.	O
<EOS>	----
Re	B-Diagnostic_Procedure
-	I-Diagnostic_Procedure
examination	I-Diagnostic_Procedure
/	O
Re	B-Health_Care_Activity
-	I-Health_Care_Activity
evaluation	I-Health_Care_Activity
:	O
Time	O
09	O
/	O
13	O
/	O
2020	O
00	O
:	O
48	O
:	O
00	O
,	O
Notes	O
I	O
received	O
signout	O
from	O
my	O
colleague	O
L	O
,	O
MD	O
.	O
<EOS>	----
Briefly	O
,	O
M	O
is	O
a	O
13	O
year	O
-	O
old	O
boy	O
with	O
hypotonia	B-Disease_or_Syndrome
,	O
choreoathetosis	B-Disease_or_Syndrome
,	O
intractable	B-Disease_or_Syndrome
epilepsy	I-Disease_or_Syndrome
and	O
intellectual	B-Disease_or_Syndrome
disability	I-Disease_or_Syndrome
presenting	O
with	O
increased	B-Quantitative_Concept
agitation	I-Sign_or_Symptom
and	O
tachycardia	B-Finding
for	O
the	O
past	O
day	O
.	O
<EOS>	----
Of	O
note	O
,	O
he	O
has	O
had	O
a	O
recent	O
admission	O
for	O
tachycardia	B-Finding
in	O
the	O
setting	O
of	O
recent	B-Temporal_Concept
spinal	B-Therapeutic_or_Preventive_Procedure
fusion	I-Therapeutic_or_Preventive_Procedure
w	O
/	O
multiple	B-Quantitative_Concept
complications	B-Pathologic_Function
(	O
including	O
post	B-Temporal_Concept
-	B-Temporal_Concept
op	B-Temporal_Concept
blood	B-Pathologic_Function
loss	I-Pathologic_Function
,	O
need	O
to	O
titrate	O
epilepsy	B-Pharmacologic_Substance
medications	I-Pharmacologic_Substance
,	O
pulm	B-Disease_or_Syndrome
insufficiency	I-Disease_or_Syndrome
)	O
-	O
ultimately	O
he	O
was	O
discharged	O
with	O
resting	B-Finding
heart	B-Health_Care_Activity
rate	I-Health_Care_Activity
in	O
the	O
120s	O
,	O
by	O
multidisciplinary	B-CUI_less
work	B-CUI_less
-	I-CUI_less
up	I-CUI_less
including	O
EEG	B-Diagnostic_Procedure
with	O
neuro	B-CUI_less
and	O
pain	B-Pharmacologic_Substance
medication	I-Pharmacologic_Substance
titration	B-Functional_Concept
with	O
the	O
pain	O
team	O
.	O
<EOS>	----
With	O
regards	O
to	O
tachycardia	B-CUI_less
work	I-CUI_less
-	I-CUI_less
up	I-CUI_less
in	O
the	O
ED	O
so	O
far	O
,	O
CBC	B-Laboratory_Procedure
demonstrated	O
no	O
anemia	B-Disease_or_Syndrome
and	O
he	O
was	O
euvolemic	O
on	O
exam	B-Health_Care_Activity
.	O
<EOS>	----
Proceeded	O
with	O
additional	B-CUI_less
infectious	B-CUI_less
work	I-CUI_less
-	I-CUI_less
up	I-CUI_less
given	O
increased	B-Quantitative_Concept
discomfort	B-Sign_or_Symptom
today	O
,	O
which	O
was	O
notable	O
for	O
no	O
focality	B-Qualitative_Concept
on	O
chest	B-Diagnostic_Procedure
x	I-Diagnostic_Procedure
-	I-Diagnostic_Procedure
ray	I-Diagnostic_Procedure
to	O
suggest	O
pneumonia	B-Disease_or_Syndrome
.	O
<EOS>	----
Ortho	O
also	O
saw	O
patient	O
evaluated	O
surgical	B-Therapeutic_or_Preventive_Procedure
incision	I-Therapeutic_or_Preventive_Procedure
and	O
there	O
was	O
no	O
surgical	B-Pathologic_Function
infection	I-Pathologic_Function
.	O
<EOS>	----
UA	B-Laboratory_Procedure
demonstrated	O
52	O
white	B-Laboratory_Procedure
blood	I-Laboratory_Procedure
cells	I-Laboratory_Procedure
and	O
2	O
+	O
positive	B-Laboratory_or_Test_Result
leuk	B-Laboratory_Procedure
esterase	I-Laboratory_Procedure
most	O
suggestive	O
of	O
a	B-Disease_or_Syndrome
urinary	I-Disease_or_Syndrome
tract	I-Disease_or_Syndrome
infection	I-Disease_or_Syndrome
.	O
<EOS>	----
Obtained	O
abdominal	B-Diagnostic_Procedure
ultrasound	I-Diagnostic_Procedure
to	O
further	O
evaluate	O
kidneys	O
which	O
showed	O
no	O
demonstration	O
of	O
any	O
renal	B-Disease_or_Syndrome
abscess	I-Disease_or_Syndrome
or	O
pyelonephritis	B-Disease_or_Syndrome
.	O
<EOS>	----
Administered	O
1	O
dose	O
of	O
ceftriaxone	B-Antibiotic
and	O
discharged	O
on	O
7	O
-	O
day	O
course	O
of	O
Keflex	B-Pharmacologic_Substance
.	O
<EOS>	----
Abdominal	B-Diagnostic_Procedure
ultrasound	I-Diagnostic_Procedure
also	O
showed	O
seroma	B-Pathologic_Function
(	O
w/o	O
assoc	B-CUI_less
hyperemia	I-Finding
)	O
around	O
post	O
.	O
<EOS>	----
midline	B-Spatial_Concept
spinal	B-Therapeutic_or_Preventive_Procedure
fusion	I-Therapeutic_or_Preventive_Procedure
incision	B-Spatial_Concept
site	I-Spatial_Concept
which	O
I	O
discussed	O
with	O
on	O
-	O
call	O
Ortho	O
resident	O
who	O
said	O
this	O
was	O
an	O
expected	O
finding	O
and	O
no	O
acute	O
concern	O
.	O
<EOS>	----
Of	O
note	O
,	O
heart	B-Health_Care_Activity
rate	I-Health_Care_Activity
is	O
downtrending	O
to	O
the	O
110s	O
during	O
much	O
of	O
the	O
time	O
I	O
was	O
covering	O
for	O
this	O
patient	O
.	O
<EOS>	----
Discharge	O
vital	B-Health_Care_Activity
sign	I-Health_Care_Activity
of	O
heart	B-Health_Care_Activity
rate	I-Health_Care_Activity
133	O
was	O
in	O
the	O
setting	O
of	O
just	O
finishing	O
respiratory	B-CUI_less
/	I-CUI_less
pulmonary	I-CUI_less
toilet	I-CUI_less
(	O
including	O
Atrovent	B-Pharmacologic_Substance
and	O
hypertonic	B-Clinical_Drug
saline	I-Pharmacologic_Substance
nebs	B-Therapeutic_or_Preventive_Procedure
,	O
CoughAssist	B-Finding
,	O
etc	O
.	O
)	O
.	O
<EOS>	----
I	O
discussed	O
all	O
laboratory	B-CUI_less
and	I-CUI_less
imaging	I-CUI_less
findings	I-CUI_less
with	O
his	O
mother	O
,	O
as	O
well	O
as	O
plan	O
of	O
care	O
for	O
treatment	O
of	O
UTI	B-Disease_or_Syndrome
.	O
<EOS>	----
She	O
expressed	O
understanding	O
and	O
agreed	O
with	O
plan	O
for	O
discharge	O
home	O
.	O
<EOS>	----
We	O
have	O
reviewed	O
return	B-Therapeutic_or_Preventive_Procedure
precautions	I-Therapeutic_or_Preventive_Procedure
including	O
fever	B-Sign_or_Symptom
/	O
temp	B-Sign_or_Symptom
instability	I-Finding
while	O
on	O
Keflex	B-Pharmacologic_Substance
,	O
signs	B-CUI_less
of	O
dehydration	B-Disease_or_Syndrome
,	O
urinary	B-Disease_or_Syndrome
retention	I-Disease_or_Syndrome
,	O
increasing	B-Functional_Concept
agitation	B-Sign_or_Symptom
or	O
lethargy	B-Sign_or_Symptom
,	O
vomiting	B-Sign_or_Symptom
or	O
apparent	B-CUI_less
abdominal	B-Sign_or_Symptom
pain	I-Sign_or_Symptom
,	O
worsening	B-Qualitative_Concept
tachycardia	B-Finding
despite	O
treatment	B-Therapeutic_or_Preventive_Procedure
of	O
UTI	B-Disease_or_Syndrome
.	O
<EOS>	----
H	O
,	O
MD	O
/	O
PhD	O
<EOS>	----
Impression	O
and	O
Plan	O
<EOS>	----
Diagnosis	O
<EOS>	----
Tachycardia	B-Finding
785.0	O
(	O
ICD10	B-CUI_less
-	I-CUI_less
CM	I-CUI_less
R00.0	O
,	O
Discharge	O
,	O
Medical	O
)	O
<EOS>	----
Urinary	B-Disease_or_Syndrome
tract	I-Disease_or_Syndrome
infection	I-Disease_or_Syndrome
(	O
ICD10	O
-	O
CM	O
N39.0	O
,	O
Discharge	O
,	O
Medical	O
)	O
<EOS>	----
Developmental	B-Finding
delay	I-Finding
(	O
ICD10	B-CUI_less
-	O
CM	O
R62.50	O
,	O
Discharge	O
,	O
Medical	O
)	O
<EOS>	----
Calls	O
-	O
Consults	O
<EOS>	----
-	O
Ortho	O
.	O
<EOS>	----
Plan	O
<EOS>	----
Condition	O
:	O
Improved	O
.	O
<EOS>	----
Disposition	O
:	O
Discharged	O
:	O
Time	O
09	O
/	O
13	O
/	O
2020	O
02	O
:	O
55	O
:	O
00	O
,	O
to	O
home	O
.	O
<EOS>	----
Patient	O
was	O
given	O
the	O
following	O
educational	O
materials	O
:	O
Urinary	B-Disease_or_Syndrome
Tract	I-Disease_or_Syndrome
Infection	I-Disease_or_Syndrome
(	O
UTI	B-Disease_or_Syndrome
)	O
.	O
<EOS>	----
Follow	O
up	O
with	O
:	O
Primary	O
Care	O
Physician	O
,	O
In	O
:	O
1	O
-	O
2	O
days	O
to	O
continue	O
to	O
trend	O
HR	O
/	O
comfort	O
level	O
.	O
<EOS>	----
Counseled	O
:	O
Family	O
,	O
Regarding	O
diagnosis	O
,	O
Regarding	O
diagnostic	O
results	O
,	O
Regarding	O
treatment	O
plan	O
,	O
Regarding	O
prescription	O
,	O
Patient	O
indicated	O
understanding	O
of	O
instructions	O
.	O
<EOS>	----
Addendum	O
<EOS>	----
Teaching	O
-	O
Supervisory	O
Addendum	O
-	O
Brief	O
<EOS>	----
I	O
participated	O
in	O
the	O
following	O
activities	O
of	O
this	O
patients	O
care	O
:	O
the	B-Health_Care_Activity
medical	I-Health_Care_Activity
history	I-Health_Care_Activity
,	O
the	B-Health_Care_Activity
physical	I-Health_Care_Activity
exam	I-Health_Care_Activity
,	O
medical	O
decision	O
making	O
.	O
<EOS>	----
I	O
personally	O
performed	O
:	O
supervision	O
of	O
the	O
patient	O
's	O
care	O
,	O
the	B-Health_Care_Activity
medical	I-Health_Care_Activity
history	I-Health_Care_Activity
,	O
the	B-Health_Care_Activity
physical	I-Health_Care_Activity
exam	I-Health_Care_Activity
.	O
<EOS>	----
The	O
case	O
was	O
discussed	O
with	O
:	O
the	O
resident	O
.	O
<EOS>	----
Evaluation	O
and	O
management	O
service	O
:	O
I	O
agree	O
with	O
the	O
evaluation	O
and	O
management	O
decisions	O
made	O
in	O
this	O
patient	O
's	O
care	O
.	O
<EOS>	----
Results	O
interpretation	O
:	O
I	O
agree	O
with	O
the	O
study	O
interpretation	O
in	O
this	O
patient	O
's	O
care	O
.	O
<EOS>	----
Notes	O
:	O
13	O
-	O
year	O
-	O
old	O
male	O
with	O
multiple	B-CUI_less
medical	I-CUI_less
problems	I-CUI_less
who	O
is	O
status	O
post	O
spinal	B-Therapeutic_or_Preventive_Procedure
fusion	I-Therapeutic_or_Preventive_Procedure
1	O
month	O
ago	O
and	O
now	O
presents	O
with	O
recurrent	B-Temporal_Concept
and	O
persistent	B-Temporal_Concept
tachycardia	B-Finding
in	O
the	O
absence	O
of	O
fever	B-Sign_or_Symptom
or	O
obvious	B-CUI_less
source	O
.	O
<EOS>	----
On	O
exam	B-Health_Care_Activity
he	O
is	O
mostly	O
his	O
baseline	O
.	O
<EOS>	----
Lungs	O
are	O
clear	O
,	O
cardiac	B-Health_Care_Activity
exam	I-Health_Care_Activity
is	O
normal	O
other	O
than	O
tachycardia	B-Finding
,	O
the	O
rest	O
of	O
the	B-Disease_or_Syndrome
PE	I-Disease_or_Syndrome
is	O
as	O
above	O
.	O
<EOS>	----
We	O
checked	O
CBC	B-Laboratory_Procedure
to	O
evaluate	O
for	O
anemia	B-Disease_or_Syndrome
as	O
well	O
as	O
infection	B-Disease_or_Syndrome
,	O
electrolytes	B-Laboratory_Procedure
to	O
evaluate	O
for	O
dehydration	B-Disease_or_Syndrome
,	O
blood	B-Laboratory_Procedure
culture	I-Laboratory_Procedure
ESR	B-Laboratory_Procedure
CRP	B-Laboratory_Procedure
.	O
<EOS>	----
We	O
also	O
obtained	O
x	B-Diagnostic_Procedure
-	I-Diagnostic_Procedure
rays	I-Diagnostic_Procedure
of	O
the	O
T	B-Body_Location_or_Region
-	I-Body_Location_or_Region
spine	I-Body_Location_or_Region
the	O
chest	B-Body_Location_or_Region
and	O
the	O
abdomen	O
to	O
evaluate	O
for	O
breakage	B-Pathologic_Function
of	I-Pathologic_Function
the	I-Medical_Device
hardware	I-Medical_Device
,	O
pneumonia	B-Disease_or_Syndrome
or	O
increased	B-Finding
heart	I-Finding
size	I-Finding
or	O
stool	B-Laboratory_or_Test_Result
burden	I-Laboratory_or_Test_Result
.	O
<EOS>	----
All	O
reassuring	O
except	O
for	O
large	B-Quantitative_Concept
stool	B-Laboratory_or_Test_Result
burden	I-Laboratory_or_Test_Result
.	O
,	O
A	B-Laboratory_Procedure
urine	I-Laboratory_Procedure
test	I-Laboratory_Procedure
revealed	O
52	O
whites	O
.	O
<EOS>	----
A	B-Laboratory_Procedure
culture	I-Laboratory_Procedure
is	O
pending	O
.	O
<EOS>	----
Appreciate	O
orthopedics	O
consult	O
.	O
<EOS>	----
We	O
placed	O
him	O
on	O
BiPAP	B-Pharmacologic_Substance
as	O
he	O
is	O
normally	O
on	O
this	O
at	O
night	O
and	O
provided	O
him	O
with	O
his	O
normal	O
nighttime	O
meds	B-CUI_less
.	O
<EOS>	----
His	B-Health_Care_Activity
heart	I-Health_Care_Activity
rate	I-Health_Care_Activity
came	O
back	O
down	O
to	O
elbow	O
120s	O
in	O
high	O
1	O
teens	O
which	O
is	O
approximately	O
where	O
it	O
was	O
upon	O
discharge	O
during	O
his	O
admission	O
earlier	O
this	O
month	O
.	O
<EOS>	----
He	O
was	O
given	O
ceftriaxone	B-Antibiotic
empirically	O
for	O
probable	O
UTI	B-Disease_or_Syndrome
.	O
<EOS>	----
Anticipate	O
discharge	O
on	O
Keflex	B-Pharmacologic_Substance
for	O
UTI	B-Disease_or_Syndrome
.	O
<EOS>	----
In	O
the	O
meantime	O
obtain	O
ultrasound	B-Diagnostic_Procedure
to	O
evaluate	O
for	O
any	O
sort	O
of	O
fluid	B-Pathologic_Function
collection	I-Pathologic_Function
that	O
could	O
also	O
explain	O
his	B-Finding
tachycardia	I-Finding
.	O
<EOS>	----
Signing	O
out	O
to	O
Dr.	O
M	O
at	O
1	O
AM	O
,	O
I	O
received	O
sign	O
out	O
from	O
Dr.	O
Fat	B-CUI_less
shift	I-CUI_less
change	I-CUI_less
.	O
<EOS>	----
I	O
participated	O
in	O
the	O
care	O
of	O
this	O
patient	O
.	O
<EOS>	----
History	O
reviewed	O
with	O
patient	O
/	O
family	O
and	O
trainee	O
.	O
<EOS>	----
Physical	B-Health_Care_Activity
exam	I-Health_Care_Activity
performed	O
by	O
me	O
.	O
<EOS>	----
I	O
supervised	O
the	O
care	O
of	O
this	O
patient	O
.	O
<EOS>	----
Briefly	O
,	O
13	O
yo	O
M	O
complex	O
pmh	O
who	O
p	O
/	O
w	O
with	O
recurrent	B-Temporal_Concept
and	O
persistent	B-Temporal_Concept
tachycardia	B-Finding
.	O
<EOS>	----
Otherwise	O
at	O
baseline	O
.	O
<EOS>	----
Here	O
in	O
ED	O
workup	B-CUI_less
completed	O
which	O
elucidated	O
a	B-Laboratory_Procedure
UA	I-Laboratory_Procedure
concerning	O
for	O
urinary	B-Disease_or_Syndrome
tract	I-Disease_or_Syndrome
infection	I-Disease_or_Syndrome
.	O
<EOS>	----
Patient	O
had	O
improved	O
vital	B-Health_Care_Activity
signs	I-Health_Care_Activity
,	O
downward	B-Spatial_Concept
trending	I-Laboratory_or_Test_Result
tachycardia	B-Finding
to	O
the	O
110	O
's	O
.	O
<EOS>	----
Plan	O
was	O
made	O
to	O
discharge	O
home	O
,	O
antibiotics	B-Antibiotic
for	O
urinalysis	B-Laboratory_Procedure
,	O
follow	O
-	O
up	O
with	O
primary	O
care	O
provider	O
in	O
2	O
days	O
,	O
ED	O
return	B-Temporal_Concept
precautions	B-Therapeutic_or_Preventive_Procedure
were	O
discussed	O
with	O
family	O
which	O
include	O
worsening	B-Qualitative_Concept
tachycardia	B-Finding
,	O
changes	B-Finding
in	I-Finding
respiratory	I-Finding
status	I-Finding
,	O
or	O
any	O
other	B-CUI_less
concerns	B-CUI_less
.	O
<EOS>	----
Patient	O
observed	O
in	O
ED	O
and	O
serial	B-Quantitative_Concept
exams	B-Health_Care_Activity
performed	O
.	O
<EOS>	----
Remained	O
well	O
appearing	O
without	O
evidence	O
of	O
cardivascular	B-Body_Part,_Organ,_or_Organ_Component
,	O
respiratory	O
,	O
or	O
neurologic	B-Finding
compromise	I-CUI_less
.	O
<EOS>	----
Safe	O
for	O
discharge	O
home	O
.	O
<EOS>	----
Instructions	O
given	O
to	O
family	O
.	O
<EOS>	----
ED	B-Therapeutic_or_Preventive_Procedure
return	B-Therapeutic_or_Preventive_Procedure
precautions	I-Therapeutic_or_Preventive_Procedure
discussed	O
with	O
family	O
.	O
<EOS>	----
Family	O
was	O
in	O
agreement	O
with	O
the	O
discharge	O
plan	O
.	O
<EOS>	----
End of note3.txt	----------


